<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants - Pammi, M - 2020 | Cochrane Library</title> <meta content="Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants - Pammi, M - 2020 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007137.pub6/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants - Pammi, M - 2020 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007137.pub6/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD007137.pub6" name="dc.identifier" scheme="DOI"/> <meta content="Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants" name="citation_title"/> <meta content="Mohan Pammi" name="citation_author"/> <meta content="Baylor College of Medicine" name="citation_author_institution"/> <meta content="mohanv@bcm.tmc.edu" name="citation_author_email"/> <meta content="Kanekal S Gautham" name="citation_author"/> <meta content="Baylor College of Medicine" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="3" name="citation_issue"/> <meta content="10.1002/14651858.CD007137.pub6" name="citation_doi"/> <meta content="2020" name="citation_date"/> <meta content="2020/03/31" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007137.pub6/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007137.pub6/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007137.pub6/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Administration, Oral; Bacterial Infections [epidemiology, prevention &amp; control]; Cause of Death; Chronic Disease; *Enteral Nutrition; Enterocolitis, Necrotizing [epidemiology, *prevention &amp; control]; Infant, Premature; Infant, Premature, Diseases [*prevention &amp; control]; Lacticaseibacillus rhamnosus; Lactoferrin [*administration &amp; dosage]; Lung Diseases [epidemiology]; Mycoses [epidemiology, prevention &amp; control]; Numbers Needed To Treat; Probiotics [*administration &amp; dosage]; Randomized Controlled Trials as Topic; Retinopathy of Prematurity [epidemiology]; Sepsis [*prevention &amp; control]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007137.pub6&amp;doi=10.1002/14651858.CD007137.pub6&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007137.pub6&amp;doi=10.1002/14651858.CD007137.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007137.pub6&amp;doi=10.1002/14651858.CD007137.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007137.pub6&amp;doi=10.1002/14651858.CD007137.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007137.pub6&amp;doi=10.1002/14651858.CD007137.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007137.pub6&amp;doi=10.1002/14651858.CD007137.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007137.pub6&amp;doi=10.1002/14651858.CD007137.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007137.pub6&amp;doi=10.1002/14651858.CD007137.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007137.pub6&amp;doi=10.1002/14651858.CD007137.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007137.pub6&amp;doi=10.1002/14651858.CD007137.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007137.pub6&amp;doi=10.1002/14651858.CD007137.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007137.pub6&amp;doi=10.1002/14651858.CD007137.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007137.pub6&amp;doi=10.1002/14651858.CD007137.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007137.pub6&amp;doi=10.1002/14651858.CD007137.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007137.pub6&amp;doi=10.1002/14651858.CD007137.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007137.pub6&amp;doi=10.1002/14651858.CD007137.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007137.pub6&amp;doi=10.1002/14651858.CD007137.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007137.pub6&amp;doi=10.1002/14651858.CD007137.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007137.pub6&amp;doi=10.1002/14651858.CD007137.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007137.pub6&amp;doi=10.1002/14651858.CD007137.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007137.pub6&amp;doi=10.1002/14651858.CD007137.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007137.pub6&amp;doi=10.1002/14651858.CD007137.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007137.pub6&amp;doi=10.1002/14651858.CD007137.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="18M35a5z";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD007137\x2epub6\x26doi\x3d10\x2e1002\x2f14651858\x2eCD007137\x2epub6\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007137\x2epub6\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007137\x2epub6\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","fa","fr","es","zh_HANS","de","ru","ms","ja","pl"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD007137.pub6",title:"Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants",firstPublishedDate:"Mar 31, 2020 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Neonatal Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=18M35a5z&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007137.pub6&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007137.pub6';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD007137.pub6/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD007137.pub6/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007137.pub6%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD007137.PUB6" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD007137.pub6/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD007137.PUB6" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD007137.pub6/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD007137.pub6/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>6360 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD007137.pub6" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007137.pub6/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007137.pub6/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007137.pub6/full#CD007137-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007137.pub6/full#CD007137-sec-0095"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007137.pub6/full#CD007137-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007137.pub6/full#CD007137-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007137.pub6/full#CD007137-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007137.pub6/full#CD007137-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007137.pub6/full#CD007137-sec-0039"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007137.pub6/full#CD007137-sec-0089"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007137.pub6/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007137.pub6/appendices#CD007137-sec-0100"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007137.pub6/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007137.pub6/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/table_n/CD007137StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/table_n/CD007137StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007137.pub6/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007137.pub6/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007137.pub6/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007137.pub6/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007137.pub6/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD007137.pub6/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007137.pub6/information#CD007137-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Mohan Pammi</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007137.pub6/information#CD007137-cr-0005">Kanekal S Gautham</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/information/en#CD007137-sec-0106">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 31 March 2020 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD007137.pub6">https://doi.org/10.1002/14651858.CD007137.pub6</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD007137-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007137-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007137-abs-0014">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007137-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007137-abs-0012">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD007137-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD007137-abs-0001" lang="en"> <section id="CD007137-sec-0001"> <h3 class="title" id="CD007137-sec-0001">Background</h3> <p>Lactoferrin, a normal component of human colostrum and milk, can enhance host defenses and may be effective for prevention of sepsis and necrotizing enterocolitis (NEC) in preterm neonates. </p> </section> <section id="CD007137-sec-0002"> <h3 class="title" id="CD007137-sec-0002">Objectives</h3> <p>To assess the safety and effectiveness of lactoferrin supplementation to enteral feeds for prevention of sepsis and NEC in preterm neonates. Secondarily, we assessed the effects of lactoferrin supplementation to enteral feeds on the duration of positive‐pressure ventilation, development of chronic lung disease (CLD) or periventricular leukomalacia (PVL), length of hospital stay to discharge among survivors, and adverse neurological outcomes at two years of age or later. </p> </section> <section id="CD007137-sec-0003"> <h3 class="title" id="CD007137-sec-0003">Search methods</h3> <p>We used the standard search strategy of Cochrane Neonatal to update our search. We searched the Cochrane Central Register of Controlled Trials (CENTRAL 2019, Issue 9), MEDLINE via PubMed (1966 to 20 January 2020), PREMEDLINE (1996 to 20 January 2020), Embase (1980 to 20 January 2020), and CINAHL (1982 to 20 January 2020). We also searched clinical trials databases, conference proceedings, and the reference lists of retrieved articles for randomized controlled trials and quasi‐randomized trials. </p> </section> <section id="CD007137-sec-0004"> <h3 class="title" id="CD007137-sec-0004">Selection criteria</h3> <p>In our search, we included randomized controlled trials (RCTs) evaluating enteral lactoferrin supplementation at any dose or duration to prevent sepsis or NEC in preterm neonates. </p> </section> <section id="CD007137-sec-0005"> <h3 class="title" id="CD007137-sec-0005">Data collection and analysis</h3> <p>We used the standard methods of Cochrane Neonatal and the GRADE approach to assess the certainty of evidence. </p> </section> <section id="CD007137-sec-0006"> <h3 class="title" id="CD007137-sec-0006">Main results</h3> <p>Meta‐analysis of data from twelve randomized controlled trials showed that lactoferrin supplementation to enteral feeds decreased suspected or confirmed late‐onset sepsis (typical RR 0.80, 95% CI 0.72 to 0.89; typical RD ‐0.05, 95% CI, ‐0.07 to ‐0.02; NNTB 20, 95% CI 14 to 50; 12 studies, 5425 participants, low‐certainty evidence) and decreased length of hospital stay (MD ‐2.38 to 95% CI, ‐4.67 to ‐0.09; 3 studies, 1079 participants, low‐certainty evidence). A subgroup analysis including data of infants with confirmed sepsis demonstrates a decrease in confirmed late‐onset sepsis (typical RR 0.83, 95% CI 0.73 to 0.94; typical RD ‐0.03, 95% CI, ‐0.04 to ‐0.01; NNTB 33, 95% CI 25 to 100; 12 studies, 5425 participants, low‐certainty evidence). </p> <p>Sensitivity analysis including only good methodological certainty studies suggested a decrease in late‐onset sepsis (both suspected and confirmed) with enteral lactoferrin supplementation (typical RR 0.82, 95% CI, 0.74 to 0.91; typical RD ‐0.04, 95% CI, ‐0.06 to ‐0.02; NNTB 20, 95% CI 14 to 50; 9 studies, 4702 participants, low‐certainty evidence). </p> <p>There were no differences in NEC stage II or III (typical RR 1.10, 95% CI, 0.86 to 1.41; typical RD ‐0.00, 95% CI, ‐0.02 to 0.01; 7 studies, 4874 participants; low‐certainty evidence) or 'all‐cause mortality' (typical RR 0.90, 95% CI 0.69 to 1.17; typical RD ‐0.00, 95% CI, ‐0.01 to 0.01; 11 studies, 5510 participants; moderate‐certainty evidence). One study reported no differences in neurodevelopmental testing by Mullen's or Bayley III at 24 months of age after enteral lactoferrin supplementation (one study, 292 participants, low‐certainty evidence). </p> <p>Lactoferrin supplementation to enteral feeds with probiotics decreased late‐onset sepsis (RR 0.25, 95% CI 0.14 to 0.46; RD ‐0.13, 95% CI ‐0.18 to ‐0.08; NNTB 8, 95% CI 6 to 13; 3 studies, 564 participants; low‐certainty evidence) and NEC stage II or III (RR 0.04, 95% CI 0.00 to 0.62; RD ‐0.05, 95% CI ‐0.08 to ‐0.03; NNTB 20, 95% CI 12.5 to 33.3; 1 study, 496 participants; very low‐certainty evidence), but not 'all‐cause mortality' (very low‐certainty evidence). </p> <p>Lactoferrin supplementation to enteral feeds with or without probiotics had no effect on CLD, duration of mechanical ventilation or threshold retinopathy of prematurity (low‐certainty evidence). Investigators reported no adverse effects in the included studies. </p> </section> <section id="CD007137-sec-0007"> <h3 class="title" id="CD007137-sec-0007">Authors' conclusions</h3> <p>We found low‐certainty evidence from studies of good methodological quality that lactoferrin supplementation of enteral feeds decreases late‐onset sepsis (both suspected and confirmed, and confirmed only) but not NEC ≥ stage II or 'all cause mortality' or neurodevelopmental outcomes at 24 months of age in preterm infants without adverse effects. Low‐ to very low‐certainty evidence suggests that lactoferrin supplementation of enteral feeds in combination with probiotics decreases late‐onset sepsis (data from confirmed sepsis only) and NEC ≥ stage II in preterm infants without adverse effects, however, there were few included studies of poor methodological quality. The presence of publication bias and small studies of poor methodology that may inflate the effect size make recommendations for clinical practice difficult. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD007137-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007137-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD007137-abs-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD007137-abs-0015">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007137-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007137-abs-0013">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD007137-abs-0008">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD007137-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD007137-abs-0011">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD007137-abs-0006">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD007137-abs-0004">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD007137-abs-0002" lang="en"> <h3>Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants </h3> <p><b>Review question:</b> Does administering lactoferrin with feeds decrease the risk of sepsis or necrotizing enterocolitis in preterm babies? </p> <p><b>Background:</b> Preterm babies are at risk for blood infection (sepsis) and/or gastrointestinal injury (necrotizing enterocolitis, or NEC). Many babies with sepsis or NEC die or develop long‐term brain and lung injury despite treatment with antibiotics. Lactoferrin, a protein that is present in human milk, has been shown to be effective against infection when tested in animals and in the laboratory. Lactoferrin also enhances the ability of babies to fight infection. </p> <p><b>Study characteristics:</b> Through literature searches updated to 20 January 2020, we found 12 studies that enrolled 5425 preterm babies and tested the effects of lactoferrin given with feeds. We also found ongoing studies that may increase the strength of our findings when their results become available. </p> <p><b>Key results:</b> Lactoferrin given with feeds with or without a probiotic decreases blood infection including fungal infection in preterm infants with no adverse effects. Lactoferrin with probiotics, but not lactoferrin alone, decreases gastrointestinal injury. Clarification regarding dosing, duration, type of lactoferrin (human or bovine), and development of preterm babies is still needed. </p> <p><b>Certainty of evidence:</b> Low to very low </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD007137-sec-0095" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD007137-sec-0095"></div> <h3 class="title" id="CD007137-sec-0096">Implications for practice</h3> <section id="CD007137-sec-0096"> <p>We found low‐certainty evidence that lactoferrin supplementation of enteral feeds decreases late‐onset sepsis (both suspected and confirmed, and confirmed only) but not NEC ≥ stage II, 'all cause mortality', or neurodevelopmental outcomes at 24 months of age in preterm infants without adverse effects. Low to very low‐certainty evidence suggests that lactoferrin supplementation of enteral feeds in combination with probiotics decreases late‐onset sepsis (data from confirmed sepsis only) and NEC ≥ stage II in preterm infants without adverse effects, however, there are very few studies and included studies are of poor methodological quality. Due to the presence of publication bias and small studies of poor methodology inflating the effect size, recommendations for clinical practice remain difficult. </p> </section> <h3 class="title" id="CD007137-sec-0097">Implications for research</h3> <section id="CD007137-sec-0097"> <p>Addition of data from ongoing trials to the meta‐analysis may or may not enhance the certainty and applicability of evidence for enteral lactoferrin prophylaxis in preterm infants. Study findings should also clarify effects of exclusive maternal milk feeding and addition of probiotics to lactoferrin supplementation. An individual patient data meta‐analysis is underway and may provide useful data including dosing and whether infants fed on human milk or formula will benefit the most from enteral supplementation with lactoferrin. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD007137-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD007137-sec-0008"></div> <div class="table" id="CD007137-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Lactoferrin supplementation compared to control for very low birth weight infants</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Lactoferrin supplementation compared to control for very low birth weight infants</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> prevention of sepsis and necrotizing enterocolitis in preterm infants<br/><b>Setting:</b> Neonatal intensive care unit<br/><b>Intervention:</b> lactoferrin supplementation with enteral feeds<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>What happens</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Without lactoferrin supplementation with enteral feeds</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>With lactoferrin supplementation with enteral feeds</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Difference</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>All‐cause Mortality<br/>№ of participants: 5510<br/>(11 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>RR 0.97<br/>(0.79 to 1.20) </p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY </p> <p>LOW<sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Risk of bias, imprecision and funnel plot asymmetry</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5.9%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.7%<br/>(4.6 to 7) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2% fewer<br/>(1.2 fewer to 1.2 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>necrotizing enterocolitis<br/>№ of participants: 4874<br/>(7 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>RR 0.90<br/>(0.69 to 1.17) </p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Risk of bias in the included trials, and imprecision</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4.7%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.2%<br/>(3.2 to 5.5) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.5% fewer<br/>(1.4 fewer to 0.8 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Late onset sepsis<br/>№ of participants: 5425<br/>(12 RCTs) </p> <p>[Data includes both suspected and confirmed sepsis]</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>RR 0.80<br/>(0.72 to 0.89) </p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Risk of bias in the included trials, and asymmetry of the funnel plot</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>21.1%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17.3%<br/>(15.6 to 19.2) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.8% fewer<br/>(5.5 fewer to 1.9 fewer) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Bacterial sepsis<br/>№ of participants: 3565<br/>(8 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>RR 0.86<br/>(0.74 to 1.00) </p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Risk of bias and. moderate heterogeneity</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>16.1%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.9%<br/>(11.9 to 16.1) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.3% fewer<br/>(4.2 fewer to 0 fewer) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Fungal infection<br/>№ of participants: 3266<br/>(6 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>RR 0.23<br/>(0.10 to 0.54) </p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Risk of bias and moderate heterogeneity</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1.7%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.4%<br/>(0.2 to 0.9) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.3% fewer<br/>(1.5 fewer to 0.8 fewer) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Chronic lung disease<br/>№ of participants: 2984<br/>(5 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>RR 1.00<br/>(0.89 to 1.12) </p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Low risk of bias, moderate heterogeneity and imprecision</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>27.2%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27.2%<br/>(24.2 to 30.5) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.0% fewer<br/>(3 fewer to 3.3 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Length of hospital stay<br/>№ of participants: 1079<br/>(3 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean length of hospital stay without lactoferrin supplementation with enteral feeds was 34.14 days </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 2.38 days lower<br/>(4.67 lower to 0.09 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW<sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk of bias and severe heterogeneity</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Risk of bias, <sup>2</sup>imprecision, <sup>3</sup>funnel plot asymmetry </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD007137-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Lactoferrin supplementation with enteral feeds in combination with probiotics compared to placebo for prevention of sepsis and necrotizing enterocolitis in preterm infants</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Lactoferrin supplementation with enteral feeds in combination with probiotics compared to placebo for prevention of sepsis and</b> necrotiz<b>ing enterocolitis in preterm infants</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> prevention of sepsis and necrotizing enterocolitis in preterm infants<br/><b>Setting:</b> Neonatal Intensive care unit<br/><b>Intervention:</b> Lactoferrin supplementation with enteral feeds in combination with probiotics<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with placebo</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with Lactoferrin supplementation with enteral feeds in combination with probiotics</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Any late‐onset sepsis ‐ All infants</p> <p>[Data on only confirmed sepsis available]</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.25<br/>(0.14 to 0.46) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>564<br/>(3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Risk of bias and imprecision</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>177 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>44 per 1,000<br/>(25 to 82) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>NEC ≥ stage II</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.04</p> <p>(0.00, 0.62)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>496<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Risk of bias and two levels for imprecision</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>54 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1,000<br/>(0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>All‐cause mortality</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.58</p> <p>(0.30, 1.13)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>671<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Risk of bias and two levels for imprecision</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>69 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1,000<br/>(0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Bacterial sepsis</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.28<br/>(0.11 to 0.72) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>319<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Risk of bias and imprecision</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>119 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>33 per 1,000<br/>(13 to 86) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Fungal Infection</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.24<br/>(0.08 to 0.71) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>494<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Risk of bias and imprecision</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>70 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>17 per 1,000<br/>(6 to 50) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Chronic lung disease</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.67<br/>(0.25 to 1.79) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>319<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Risk of bias and two levels for imprecision</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>60 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>40 per 1,000<br/>(15 to 107) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Length of stay among survivors</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 2 higher<br/>(1.88 lower to 5.88 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>496<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk of bias and two levels for imprecision</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Unclear blinding of intervention and outcome assessment, <sup>2</sup> Data from only one or few studies (imprecision) </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD007137-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD007137-sec-0009"></div> <section id="CD007137-sec-0010"> <h3 class="title" id="CD007137-sec-0010">Description of the condition</h3> <p>Neonatal sepsis is the most common cause of neonatal death worldwide (<a href="./references#CD007137-bbs2-0038" title="LawnJE , Wilczynska-KetendeK , CousensSN . Estimating the causes of 4 million neonatal deaths in the year 2000. International Journal of Epidemiology2006;35(3):706-18. [DOI: 10.1093/ije/dyl043] [PMID: 16556647]">Lawn 2006</a>). The incidence of neonatal sepsis in the developed world is reported to be between one and four cases per 1000 live births (<a href="./references#CD007137-bbs2-0055" title="StollBJ . Infections of the neonatal infant. In: BehrmanRE , KliegmanR , JensonHB , editors(s). Nelson's Textbook of Pediatrics. 17th edition. Philadelphia (PA): Saunders, 2004:623-40.">Stoll 2004b</a>). In the developing world, the rate of neonatal sepsis is significantly higher (6.5 to 38 per 1000 live hospital births) (<a href="./references#CD007137-bbs2-0067" title="ZaidiAK , HuskinsWC , ThaverD , BhuttaZA , AbbasZ , GoldmannDA . Hospital-acquired neonatal infections in developing countries. Lancet2005;365(9465):1175-88. [DOI: 10.1016/S0140-6736(05)71881-X] [PMID: 15794973]">Zaidi 2005</a>). Sepsis is a particular problem in very low birth weight (VLBW) infants (birth weight &lt; 1500 g); early‐onset sepsis (sepsis in infants at &lt; 72 hours of life) occurs in about 1.5% and late‐onset sepsis in about 21% of VLBW infants (<a href="./references#CD007137-bbs2-0053" title="StollBJ , HansenN , FanaroffAA , WrightLL , CarloWA , EhrenkranzRA , et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics2002;110(2 Pt 1):285-91. [PMID: 12165580]">Stoll 2002</a>; <a href="./references#CD007137-bbs2-0056" title="StollBJ , HansenNI , HigginsRD , FanaroffAA , DuaraS , GoldbergR , et al. Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002-2003. Pediatric Infectious Disease Journal2005;24(7):635-9. [PMID: 15999007]">Stoll 2005</a>). Infections due to <i>Staphylococcus</i> and <i>Candida</i> species are among the common infections in the neonate. Mortality and morbidity (including patent ductus arteriosus, prolonged ventilation, prolonged need for intravascular access, bronchopulmonary dysplasia, necrotizing enterocolitis, and increased length of hospital stay) are significantly increased among infected infants. In a large cohort study of infants born weighing less than 1000 g, infected infants had a significantly higher incidence of adverse neurodevelopmental outcomes at follow‐up when compared with uninfected infants (<a href="./references#CD007137-bbs2-0054" title="StollBJ , HansenNI , Adams-ChapmanI , FanaroffAA , HintzSR , VohrB , et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA2004;292(19):2357-65. [DOI: 10.1001/jama.292.19.2357] [PMID: 15547163]">Stoll 2004a</a>). </p> <p>Necrotizing enterocolitis (NEC) occurs in 1% to 5% of admissions to the neonatal intensive care unit (NICU) (<a href="./references#CD007137-bbs2-0043" title="LinPW , StollBJ . Necrotizing enterocolitis. Lancet2006;368(9543):1271-83. [DOI: 10.1016/S0140-6736(06)69525-1] [PMID: 17027734]">Lin 2006</a>). The most consistent risk factors are prematurity and low birth weight. Gastrointestinal immaturity, enteral feeding (especially formula feeding), presence of bacteria, and inflammation in the gastrointestinal (GI) tract may all contribute to the development of NEC (<a href="./references#CD007137-bbs2-0043" title="LinPW , StollBJ . Necrotizing enterocolitis. Lancet2006;368(9543):1271-83. [DOI: 10.1016/S0140-6736(06)69525-1] [PMID: 17027734]">Lin 2006</a>). Host‐pathogen interactions trigger inflammation in the gut, which may contribute to the pathogenesis of NEC and septic shock (<a href="./references#CD007137-bbs2-0025" title="BlackwellTS , ChristmanJW . The role of nuclear factor-kappa B in cytokine gene regulation. American Journal of Respiratory Cell and Molecular Biology1997;17(1):3-9. [DOI: 10.1165/ajrcmb.17.1.f132] [PMID: 9224203]">Blackwell 1997</a>; <a href="./references#CD007137-bbs2-0046" title="NeishAS . Molecular aspects of intestinal epithelial cell-bacterial interactions that determine the development of intestinal inflammation. Inflammatory Bowel Diseases2004;10(2):159-68. [PMID: 15168817]">Neish 2004</a>). NEC significantly increases mortality (attributable mortality of 15% to 30%) and morbidity (including surgery in 20% to 40% of infants and delayed neurodevelopment) (<a href="./references#CD007137-bbs2-0023" title="BellMJ , TernbergJL , FeiginRD , KeatingJP , MarshallR , BartonL , et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Annals of Surgery1978;187(1):1-7. [PMID: 413500]">Bell 1978</a>; <a href="./references#CD007137-bbs2-0043" title="LinPW , StollBJ . Necrotizing enterocolitis. Lancet2006;368(9543):1271-83. [DOI: 10.1016/S0140-6736(06)69525-1] [PMID: 17027734]">Lin 2006</a>; <a href="./references#CD007137-bbs2-0054" title="StollBJ , HansenNI , Adams-ChapmanI , FanaroffAA , HintzSR , VohrB , et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA2004;292(19):2357-65. [DOI: 10.1001/jama.292.19.2357] [PMID: 15547163]">Stoll 2004a</a>). </p> <p>Mortality and morbidity due to sepsis and NEC remain high despite the use of potent anti‐microbial agents (<a href="./references#CD007137-bbs2-0053" title="StollBJ , HansenN , FanaroffAA , WrightLL , CarloWA , EhrenkranzRA , et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics2002;110(2 Pt 1):285-91. [PMID: 12165580]">Stoll 2002</a>; <a href="./references#CD007137-bbs2-0056" title="StollBJ , HansenNI , HigginsRD , FanaroffAA , DuaraS , GoldbergR , et al. Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002-2003. Pediatric Infectious Disease Journal2005;24(7):635-9. [PMID: 15999007]">Stoll 2005</a>). Increased use of anti‐microbials has led to the emergence of antibiotic‐resistant strains of bacteria (<a href="./references#CD007137-bbs2-0042" title="LevySB . Antimicrobial resistance: bacteria on the defence. Resistance stems from misguided efforts to try to sterilize our environment. BMJ1998;317(7159):612-3. [PMID: 9727983]">Levy 1998</a>). Adverse pulmonary and neurodevelopmental outcomes after sepsis or NEC may be due to inflammatory injury (<a href="./references#CD007137-bbs2-0020" title="Adams-ChapmanI , StollBJ . Neonatal infection and long-term neurodevelopmental outcome in the preterm infant. Current Opinion in Infectious Diseases2006;19(3):290-7. [DOI: 10.1097/01.qco.0000224825.57976.87] [PMID: 16645492]">Adams‐Chapman 2006</a>; <a href="./references#CD007137-bbs2-0052" title="SpeerCP . Inflammatory mechanisms in neonatal chronic lung disease. European Journal of Pediatrics1999;158 Suppl 1:S18-22. [PMID: 10592094]">Speer 1999</a>). Agents that modulate inflammation and enhance host defenses may improve the outcomes of infants with neonatal sepsis or NEC. </p> </section> <section id="CD007137-sec-0011"> <h3 class="title" id="CD007137-sec-0011">Description of the intervention</h3> <p>The glycoprotein lactoferrin is a component of the innate immune response and a potent immunomodulator (<a href="./references#CD007137-bbs2-0040" title="LegrandD . Overview of lactoferrin as a natural immune modulator. Journal of Pediatrics2016;173 Suppl:S10-5. [DOI: 10.1016/j.jpeds.2016.02.071] [PMID: 27234406]">Legrand 2016</a>). It is found in significant concentrations in human colostrum and in lower concentrations in human milk, tears, saliva, and seminal fluid, and in secondary granules of neutrophils. Lactoferrin has broad‐spectrum, anti‐microbial activity against bacteria, fungi, viruses, and protozoa, which may result from its ability to sequester iron, or may occur as a direct lytic effect on microbial cell membranes (<a href="./references#CD007137-bbs2-0063" title="ValentiP , AntoniniG . Lactoferrin: an important host defence against microbial and viral attack. Cellular and Molecular Life Sciences2005;62(22):2576-87. [DOI: 10.1007/s00018-005-5372-0] [PMID: 16261253]">Valenti 2005</a>). Proteolysis of lactoferrin under acidic conditions (as would occur in the stomach or in the phagolysosomes of neutrophils) yields peptides called lactoferricins, which have enhanced anti‐microbial activity (<a href="./references#CD007137-bbs2-0030" title="GiffordJL , HunterHN , VogelHJ . Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties. Cellular and Molecular Life Sciences2005;62(22):2588-98. [DOI: 10.1007/s00018-005-5373-z] [PMID: 16261252]">Gifford 2005</a>). </p> <p>Current increased interest in lactoferrin stems not only from improved understanding of its functions, but also from its increased availability in various forms and sources. Lactoferrin processed from bovine and human milk is available commercially as a food supplement (Swedish Dairies Association, Tatua Co‐operative Dairy Company in New Zealand, Lacto Bretagne Associes' in Belgium, Milei in Germany, Morinaga Industries in Japan, DoMO Food Ingredients, a subsidiary of Friesland Dairy Foods, in the Netherlands, etc). In the United States, human recombinant lactoferrin (talactoferrin from Agennix, Inc., Houston, Texas, USA) has an investigational new drug status for clinical research purposes. Lactoferrin expression in transgenic rice (Ventrus Biosciences, New York City, New York, USA) and in transgenic maize (Meristem Therapeutics, Clermont‐Ferrand, France) is being researched. Bovine lactoferrin is less expensive than human lactoferrin and is affordable even in developing countries. </p> </section> <section id="CD007137-sec-0012"> <h3 class="title" id="CD007137-sec-0012">How the intervention might work</h3> <p>Lactoferrin inhibits the growth of <i>Staphylococcus epidermidis</i> and <i>Candida albicans</i> in vitro (<a href="./references#CD007137-bbs2-0063" title="ValentiP , AntoniniG . Lactoferrin: an important host defence against microbial and viral attack. Cellular and Molecular Life Sciences2005;62(22):2576-87. [DOI: 10.1007/s00018-005-5372-0] [PMID: 16261253]">Valenti 2005</a>). It reduces the minimum inhibitory concentrations of vancomycin against <i>S epidermidis</i> and of antifungal agents such as azoles and amphotericin against <i>Candida</i> (<a href="./references#CD007137-bbs2-0037" title="KuipersME , De VriesHG , EikelboomMC , MeijerDK , SwartPJ . Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates. Antimicrobial Agents and Chemotherapy1999;43(11):2635-41. [PMID: 10543740]">Kuipers 1999</a>; <a href="./references#CD007137-bbs2-0041" title="LeitchEC , WillcoxMD . Lactoferrin increases the susceptibility of S. epidermidis biofilms to lysozyme and vancomycin. Current Eye Research1999;19(1):12-9. [PMID: 10415452]">Leitch 1999</a>). Lactoferrin and lactoferrin‐derived peptides are highly effective in vitro against antibiotic‐resistant <i>Klebseilla</i> and <i>Staphylococcus aureus</i> (<a href="./references#CD007137-bbs2-0047" title="NibberingPH , RavensbergenE , WellingMM , Van BerkelLA , Van BerkelPH , PauwelsEK , et al. Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria. Infection and Immunity2001;69(3):1469-76. [DOI: 10.1128/IAI.69.3.1469-1476.2001] [PMID: 11179314]">Nibbering 2001</a>). </p> <p>Lactoferrin prophylaxis is effective in animal models of systemic and intestinal infection. In mice infected with <i>Escherichia coli</i>, pretreatment with lactoferrin improved survival from 4% to 70% (<a href="./references#CD007137-bbs2-0066" title="ZagulskiT , LipinskiP , ZagulskaA , BroniekS , JarzabekZ . Lactoferrin can protect mice against a lethal dose of Escherichia coli in experimental infection in vivo. British Journal of Experimental Pathology1989;70(6):697-704. [PMID: 2690922]">Zagulski 1989</a>). In neonatal rats, lactoferrin reduced the severity of blood and liver infection after enteral infection with <i>E coli</i> (<a href="./references#CD007137-bbs2-0029" title="EddeL , HipolitoRB , HwangFF , HeadonDR , ShalwitzRA , ShermanMP . Lactoferrin protects neonatal rats from gut-related systemic infection. American Journal of Physiology. Gastrointestinal and Liver Physiology2001;281(5):G1140-50. [DOI: 10.1152/ajpgi.2001.281.5.G1140] [PMID: 11668022]">Edde 2001</a>). Parenteral prophylaxis with lactoferrin enhanced survival in a neonatal rat model of polymicrobial infection with <i>C albicans</i> and <i>S epidermidis</i> (<a href="./references#CD007137-bbs2-0064" title="VenkateshM , PhamD , KongL , WeismanL . Prophylaxis with lactoferrin, a novel antimicrobial agent, enhances survival in a neonatal rat model of co-infection. Advances in Therapy2007;24(5):941-54. [PMID: 18029319]">Venkatesh 2007</a>). In a germ‐free, colostrum‐deprived piglet model challenged with <i>E coli</i> lipopolysaccharide, oral pretreatment with lactoferrin reduced mortality from 74 % to 17% after a challenge with <i>E coli</i> lipopolysaccharide (<a href="./references#CD007137-bbs2-0039" title="LeeWJ , FarmerJL , HiltyM , KimYB . The protective effects of lactoferrin feeding against endotoxin lethal shock in germfree piglets. Infect Immun1998;66:1421-6.">Lee 1998</a>). In animal colitis, lactoferrin reduced intestinal injury and inflammation (<a href="./references#CD007137-bbs2-0059" title="TogawaJ , NagaseH , TanakaK , InamoriM , UmezawaT , NakajimaA , et al. Lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. American Journal of Physiology. Gastrointestinal and Liver Physiology2002;283(1):G187-95. [DOI: 10.1152/ajpgi.00331.2001] [PMID: 12065306]">Togawa 2002</a>). The systemic effects of oral lactoferrin generally are thought to be indirect and probably are initiated by contact with intestinal epithelial cells and gut‐associated lymphoid tissue (GALT). Lactoferrin modulates cytokine and/or chemokine production by GALT cells, which then enter the systemic circulation and influence circulating leukocytes (<a href="./references#CD007137-bbs2-0024" title="BellamyW , TakaseM , WakabayashiH , KawaseK , TomitaM . Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. Journal of Applied Bacteriology1992;73(6):472-9. [PMID: 1490908]">Bellamy 1992</a>; <a href="./references#CD007137-bbs2-0060" title="TomitaM , WakabayashiH , YamauchiK , TeraguchiS , HayasawaH . Bovine lactoferrin and lactoferricin derived from milk: production and applications. Biochemistry and Cell Biology2002;80(1):109-12. [PMID: 11908633]">Tomita 2002</a>). Lactoferrin and other similar products in milk (probiotics) create an environment for growth of beneficial bacteria within the gut, reducing colonization with pathogenic bacteria. Demonstrated intestinal receptors for lactoferrin and its ability to modulate intestinal cell differentiation and proliferation (<a href="./references#CD007137-bbs2-0026" title="BuccigrossiV , De MarcoG , BruzzeseE , OmbratoL , BracaleI , PolitoG , et al. Lactoferrin induces concentration-dependent functional modulation of intestinal proliferation and differentiation. Pediatric Research2007;61(4):410-4. [DOI: 10.1203/pdr.0b013e3180332c8d] [PMID: 17515863]">Buccigrossi 2007</a>) make lactoferrin a promising agent for prevention or treatment of NEC. </p> <p>In adult humans, oral recombinant human lactoferrin has been found to be safe and well tolerated. Oral lactoferrin has shown promise as an anti‐tumour agent (<a href="./references#CD007137-bbs2-0033" title="HayesTG , FalchookGF , VaradhacharyGR , SmithDP , DavisLD , DhingraHM , et al. Phase I trial of oral talactoferrin alfa in refractory solid tumors. Investigational New Drugs2006;24(3):233-40. [DOI: 10.1007/s10637-005-3690-6] [PMID: 16193240]">Hayes 2006</a>) and has been shown to reduce viremia in chronic hepatitis C infection (<a href="./references#CD007137-bbs2-0036" title="IwasaM , KaitoM , IkomaJ , TakeoM , ImotoI , YamauchiK , et al. Lactoferrin inhibits hepatitis C virus viremia in chronic hepatitis C patients with high viral loads and HCV genotype 1b. American Journal of Gastroenterology2002;97(3):766-7. [DOI: 10.1111/j.1572-0241.2002.05573.x] [PMID: 11922584]">Iwasa 2002</a>; <a href="./references#CD007137-bbs2-0057" title="TanakaK , IkedaM , NozakiA , KatoN , TsudaH , SaitoS , et al. Lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C: a pilot study. Japanese Journal of Cancer Research1999;90(4):367-71. [PMID: 10363572]">Tanaka 1999</a>). In patients with acute myeloid leukanemia and neutropenia, lactoferrin reduced the incidence, duration, and severity of bacteremia due to enteric pathogens (<a href="./references#CD007137-bbs2-0061" title="TrumplerU , StraubPW , RosenmundA . Antibacterial prophylaxis with lactoferrin in neutropenic patients. European Journal of Clinical Microbiology and Infectious Diseases1989;8(4):310-3. [PMID: 2497005]">Trumpler 1989</a>). To date, animal and human studies have reported no significant adverse effects. </p> <p>Lactoferrin provides significant potential benefit for preterm infants including anti‐microbial and immunomodulatory effects and promotion of neurodevelopment (<a href="./references#CD007137-bbs2-0045" title="ManzoniP . Clinical benefits of lactoferrin for infants and children. Journal of Pediatrics2016;173 Suppl:S43-52. [DOI: 10.1016/j.jpeds.2016.02.075] [PMID: 27234411]">Manzoni 2016</a>; <a href="./references#CD007137-bbs2-0048" title="OchoaTJ , SizonenkoSV . Lactoferrin and prematurity: a promising milk protein?Biochemistry and Cell Biology2017;95(1):22-30. [DOI: 10.1139/bcb-2016-0066] [PMID: 28085488]">Ochoa 2017</a>). Systematic reviews on probiotics in preterm infants have reported decreased NEC and mortality (<a href="./references#CD007137-bbs2-0021" title="AlFalehK , AnabreesJ . Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database of Systematic Reviews2014, Issue 4. Art. No: CD005496. [DOI: 10.1002/14651858.CD005496.pub4]">Alfaleh 2014</a>; <a href="./references#CD007137-bbs2-0028" title='DermyshiE , WangY , YanC , HongW , QiuG , GongX , et al. The "golden age" of probiotics: a systematic review and meta-analysis of randomized and observational studies in preterm infants. Neonatology2017;112(1):9-23. [DOI: 10.1159/000454668] [PMID: 28196365]'>Dermyshi 2017</a>). Lactoferrin has been reported to act synergistically with probiotic strains of bacteria, enhancing their growth and inhibiting intestinal pathogens (<a href="./references#CD007137-bbs2-0027" title="ChenPW , LiuZS , KuoTC , HsiehMC , LiZW . Prebiotic effects of bovine lactoferrin on specific probiotic bacteria. Biometals2017;30(2):237-48. [DOI: 10.1007/s10534-017-9999-8] [PMID: 28185076]">Chen 2017</a>; <a href="./references#CD007137-bbs2-0058" title="TianH , MaddoxIS , FergusonLR , ShuQ . Influence of bovine lactoferrin on selected probiotic bacteria and intestinal pathogens. Biometals2010;23(3):593-6. [DOI: 10.1007/s10534-010-9318-0] [PMID: 20217186]">Tian 2010</a>). </p> </section> <section id="CD007137-sec-0013"> <h3 class="title" id="CD007137-sec-0013">Why it is important to do this review</h3> <p>The potential beneficial effects of lactoferrin make it a promising agent for prevention of neonatal sepsis and NEC. This review evaluated the role of lactoferrin supplementation to enteral feeds in the prevention of neonatal sepsis and NEC in preterm neonates. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD007137-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD007137-sec-0014"></div> <p>To assess the safety and effectiveness of lactoferrin supplementation to enteral feeds for prevention of sepsis and NEC in preterm neonates. Secondarily, we assessed the effects of lactoferrin supplementation to enteral feeds on the duration of positive‐pressure ventilation, development of chronic lung disease (CLD) or periventricular leukomalacia (PVL), length of hospital stay to discharge among survivors, and adverse neurological outcomes at two years of age or later. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD007137-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD007137-sec-0015"></div> <section id="CD007137-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD007137-sec-0017"> <h4 class="title">Types of studies</h4> <p>Randomized or quasi‐randomized controlled trials that have been completed (published or unpublished). </p> </section> <section id="CD007137-sec-0018"> <h4 class="title">Types of participants</h4> <p>Preterm (&lt; 37 completed weeks of gestation) neonates (&lt; 28 days).</p> </section> <section id="CD007137-sec-0019"> <h4 class="title">Types of interventions</h4> <p>Lactoferrin supplementation of enteral feeds at any dosage or duration used to prevent neonatal sepsis or NEC compared with placebo or no intervention. Separate analyses were performed for oral lactoferrin given with or without additional probiotics. </p> </section> <section id="CD007137-sec-0020"> <h4 class="title">Types of outcome measures</h4> <section id="CD007137-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD007137-list-0001"> <li> <p>Confirmed or suspected sepsis during hospital stay:</p> <ol id="CD007137-list-0002"> <li> <p>Confirmed sepsis is defined as clinical signs and symptoms consistent with infection and microbiologically proven with a positive blood culture, cerebrospinal fluid (CSF) culture, urine culture (obtained by a suprapubic tap), or culture from a normally sterile site (e.g., pleural fluid, peritoneal fluid, autopsy specimens) for bacteria or fungi; </p> </li> <li> <p>Suspected sepsis is defined as clinical signs and symptoms consistent with sepsis without isolation of a causative organism. </p> </li> </ol> </li> <li> <p>NEC Bell's stage II or III during hospital stay:</p> <ol id="CD007137-list-0003"> <li> <p>necrotizing enterocolitis (NEC) (definitive NEC and perforated NEC, Bell's stage II or III) (<a href="./references#CD007137-bbs2-0023" title="BellMJ , TernbergJL , FeiginRD , KeatingJP , MarshallR , BartonL , et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Annals of Surgery1978;187(1):1-7. [PMID: 413500]">Bell 1978</a>) during hospital stay. </p> </li> </ol> </li> <li> <p>'All‐cause mortality' during hospital stay.</p> </li> </ol> </p> </section> <section id="CD007137-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD007137-list-0004"> <li> <p>Neurological outcome at two years of age or later (neurodevelopmental outcome as assessed by a validated test); </p> </li> <li> <p>Chronic lung disease (CLD) in survivors (CLD defined as oxygen requirement at 36 weeks' postmenstrual age (PMA)); </p> </li> <li> <p>Adverse outcomes directly attributable to oral lactoferrin: increased gastric residuals (gastric aspirate &gt; 10% of oral feed), vomiting, and other GI disturbances during hospital stay; </p> </li> <li> <p>Periventricular leukomalacia (PVL) (defined as necrosis of brain white matter in a characteristic distribution, i.e. in the white matter dorsal and lateral to the external angles of lateral ventricles involving particularly the centrum semi‐ovale and optic and acoustic radiations and diagnosed by magnetic resonance imaging (MRI), or as periventricular cystic lesions seen on cranial ultrasonography (<a href="./references#CD007137-bbs2-0065" title="VolpeJJ . Neurology of the Newborn. 3rd edition. Philadelphia: WB Saunders, 1995.">Volpe 1995</a>) at discharge or at neurodevelopmental follow‐up); </p> </li> <li> <p>Duration of assisted ventilation through an endotracheal tube measured in days during hospital stay; </p> </li> <li> <p>Length of hospital stay measured in days to discharge for survivors; and</p> </li> <li> <p><i>Post hoc</i> analyses of bacterial infection, fungal infection, threshold retinopathy of prematurity, and urinary tract infection. </p> </li> </ol> </p> </section> </section> </section> <section id="CD007137-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <p>We used the criteria and standard methods of Cochrane and Cochrane Neonatal (see the Cochrane Neonatal <a href="http://neonatal.cochrane.org/resources-review-authors" target="_blank">search strategy</a> for specialized register). </p> <section id="CD007137-sec-0024"> <h4 class="title">Electronic searches</h4> <p>We conducted a comprehensive search including: Cochrane Central Register of Controlled Trials (CENTRAL 2019, Issue 9) in the Cochrane Library; MEDLINE via PubMed (1966 to 20 January 2020); Embase (1980 to 20 January 2020); and CINAHL (1982 to 20 January 2020); using the following search terms: (sepsis, septicemia, septic, necroti(s)ing enterocolitis, lactoferrin, talactoferrin), plus database‐specific limiters for randomized controlled trials and neonates (see <a href="./appendices#CD007137-sec-0101">Appendix 1</a> for the full search strategies for each database). We did not apply language restrictions. </p> <p>We searched clinical trials registries for ongoing or recently completed trials (<a href="https://clinicaltrials.gov/" target="_blank">clinicaltrials.gov</a>; the World Health Organization’s International <a href="http://apps.who.int/trialsearch/default.aspx" target="_blank">Trials Registry</a> and Platform, Australian and New Zealand Clinical Trials Registry (<a href="http://www.anzctr.org.au" target="_blank">anzctr.org.au</a>) and the ISRCTN). </p> </section> <section id="CD007137-sec-0025"> <h4 class="title">Searching other resources</h4> <p>We also searched the reference lists of any articles selected for inclusion in this review in order to identify additional relevant articles. We contacted study authors who published in this field to ask about unpublished articles. We searched the abstracts of conferences from proceedings of Pediatric Academic Societies (American Pediatric Society, Society for Pediatric Research, and European Society for Pediatric Research) from 1990 to 20 January 2020 in the journal <i>Pediatric Research</i> and in <i>Abstracts Online.</i> </p> </section> </section> <section id="CD007137-sec-0026"> <h3 class="title" id="CD007137-sec-0026">Data collection and analysis</h3> <p>We used the standard methods of Cochrane Neonatal for conducting a systematic review (<a href="http://neonatal.cochrane.org/en/index.html" target="_blank">neonatal.cochrane.org/en/index.html</a>). </p> <section id="CD007137-sec-0027"> <h4 class="title">Selection of studies</h4> <p>Two review authors assessed the titles and abstracts of studies identified by the search strategy to determine eligibility for inclusion in this review. If this could not be done reliably by title and abstract review, we obtained full‐text versions for assessment. We resolved differences by mutual discussion and obtained full‐text versions of all eligible studies for certainty assessment. </p> </section> <section id="CD007137-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>We designed forms for documenting trial inclusion/exclusion, for extracting data, and for requesting additional published information from authors of the original reports. We independently extracted data using specially designed paper forms. </p> </section> <section id="CD007137-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (MP, GS) independently assessed risk of bias (low, high, or unclear) of all included trials using the Cochrane 'Risk of bias' tool (<a href="./references#CD007137-bbs2-0035" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>) for the following domains. </p> <p> <ol id="CD007137-list-0005"> <li> <p>Sequence generation (selection bias);</p> </li> <li> <p>Allocation concealment (selection bias);</p> </li> <li> <p>Blinding of participants and personnel (performance bias);</p> </li> <li> <p>Blinding of outcome assessment (detection bias);</p> </li> <li> <p>Incomplete outcome data (attrition bias);</p> </li> <li> <p>Selective reporting (reporting bias); or</p> </li> <li> <p>Any other bias.</p> </li> </ol> </p> <p>We resolved disagreements by discussion. See <a href="./appendices#CD007137-sec-0102">Appendix 2</a> for a detailed description of risk of bias for each domain.  </p> </section> <section id="CD007137-sec-0030"> <h4 class="title">Measures of treatment effect</h4> <p>We performed statistical analyses according to recommendations of Cochrane Neonatal. We analyzed all randomly assigned infants on an 'intention‐to‐treat basis,' irrespective of whether they received their allocated treatment. We analyzed treatment effects in individual trials. We used the statistical package (RevMan 5.3) provided by the Cochrane Collaboration. We reported risk ratios (RRs) and risk differences (RDs) with 95% confidence intervals (CIs) for dichotomous outcomes, and weighted mean differences for continuous outcomes. We calculated and reported the number needed to treat for an additional beneficial outcome (NNTB) or the number needed to treat for an additional harmful outcome (NNTH) for statistically significant reductions in RD. </p> </section> <section id="CD007137-sec-0031"> <h4 class="title">Unit of analysis issues</h4> <p>We included randomized and quasi‐randomized trials and used each participant as the unit of analysis. We did not encounter repeated measurements, and we excluded cluster‐randomized and cross‐over trials. </p> </section> <section id="CD007137-sec-0032"> <h4 class="title">Dealing with missing data</h4> <p>We contacted trial investigators to obtain missing data.</p> </section> <section id="CD007137-sec-0033"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed heterogeneity of treatment effects between trials using the I<sup>2</sup> statistic to check the appropriateness of pooling data and performing meta‐analyses. We deferred meta‐analysis if heterogeneity was high (≥ 75%). We used the following cut‐offs to report the degree of heterogeneity: &lt; 25% no heterogeneity; 25% to 49% low heterogeneity; 50% to 74% moderate heterogeneity; and ≥ 75% high heterogeneity. If we detected statistical heterogeneity, we explored possible causes (e.g. differences in study certainty, participants, intervention regimens, or outcome assessments) by performing post hoc subgroup analyses. </p> </section> <section id="CD007137-sec-0034"> <h4 class="title">Assessment of reporting biases</h4> <p>We assessed publication bias by visually analyzing the funnel plot for the outcome of late‐onset neonatal sepsis and 'all‐cause mortality' in the included trials (<a href="#CD007137-fig-0001">Figure 1</a>; <a href="#CD007137-fig-0002">Figure 2</a>). The visual analysis showed asymmetry of the funnel plot, with more trials with a positive outcome than trials with no effect or a negative outcome. The asymmetry may be due to publication bias but also by many small studies (<a href="./references#CD007137-bbs2-0001" title="AkinIM , AtasayB , DoguF , OkuluE , ArsanS , KaratasHD , et al. Oral lactoferrin to prevent nosocomial sepsis and necrotizing enterocolitis of premature neonates and effect on T-regulatory cells. American Journal of Perinatology2014;31(12):1111-20. [DOI: 10.1055/s-0034-1371704] [PMID: 24839144] [PMID: 24839144]">Akin 2014</a>; <a href="./references#CD007137-bbs2-0002" title="BarringtonKJ , AssaadMA , JanvierA . The Lacuna Trial: a double-blind randomized controlled pilot trial of lactoferrin supplementation in the very preterm infant. Journal of Perinatology2016;36(8):666-9. [DOI: 10.1038/jp.2016.24] [PMID: 26938920] [PMID: 26938920]">Barrington 2016</a>; <a href="./references#CD007137-bbs2-0003" title="DaiJZ , XieC . The effect of lactoferrin supplementation combining Lactobacillus rhamnosus for prevention of late onset sepsis in premature neonates. China Practical Medicine2015;10:98-100. ">Dai 2015</a>; <a href="./references#CD007137-bbs2-0005" title="KaurG , GathwalaG . Efficacy of bovine lactoferrin supplementation in preventing late-onset sepsis in low birth weight neonates: a randomized placebo-controlled clinical trial. Journal of Tropical Pediatrics2015;61(5):370-6. [DOI: 10.1093/tropej/fmv044] [PMID: 26224129]">Kaur 2015</a>; <a href="./references#CD007137-bbs2-0007" title="LiuYH , GuanHS , LiangGJ , LiYZ , ZuoA . The effect of lactoferrin on low birth weight neonates during hospitalization. Maternal and Child Health Care of China2016;31(21):4464-5. ">Liu 2016</a>; <a href="./references#CD007137-bbs2-0009" title="OchoaTJ , ZegarraJ , CamL , LlanosR , PezoA , CruzK , et al. Randomized controlled trial of lactoferrin for prevention of sepsis in Peruvian neonates less than 2500 g. Pediatric Infectious Disease Journal2015;34(6):571-6. [DOI: 10.1097/INF.0000000000000593] [PMID: 25973934]">Ochoa 2015</a>; <a href="./references#CD007137-bbs2-0011" title="ShermanMP , AdamkinDH , NiklasV , RadmacherP , ShermanJ , WertheimerF , et al. Randomized controlled trial of talactoferrin oral solution in preterm infants. Journal of Pediatrics2016;175:68-73. [DOI: 10.1016/j.jpeds.2016.04.084] [PMID: 27260839]">Sherman 2016</a>; and <a href="./references#CD007137-bbs2-0012" title="TangJP , SunHQ , ZhengYH , LuGH . Randomized control trial of lactoferrin for the prevention of late onset sepsis in premature neonates. Maternal and Child Health Care of China2017;32(6):1223-5. ">Tang 2017</a>), some with poor methodological certainty inflating the effects of enteral lactoferrin supplementation. We have downgraded the evidence based on publication bias, small studies with poor methodological certainty for the outcome of late‐onset sepsis and 'all‐cause mortality' for comparison 1. </p> <div class="figure" id="CD007137-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Lactoferrin supplementation with enteral feeds versus placebo, outcome: 1.1 Any late‐onset sepsis." data-id="CD007137-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-FIG-01.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Lactoferrin supplementation with enteral feeds versus placebo, outcome: 1.1 Any late‐onset sepsis. </p> </div> </div> </div> <div class="figure" id="CD007137-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Lactoferrin supplementation with enteral feeds versus placebo, outcome: 1.3 All‐cause mortality." data-id="CD007137-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Lactoferrin supplementation with enteral feeds versus placebo, outcome: 1.3 All‐cause mortality. </p> </div> </div> </div> </section> <section id="CD007137-sec-0035"> <h4 class="title">Data synthesis</h4> <p>We used a fixed‐effect model for meta‐analysis when appropriate, with Review Manager software (<a href="./references#CD007137-bbs2-0050" title="Nordic Cochrane Centre, The Cochrane CollaborationReview Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">RevMan 2014</a>) as recommended by Cochrane Neonatal. For estimates of typical relative risk and risk difference, we used the Mantel‐Haenszel method. </p> <section id="CD007137-sec-0036"> <h5 class="title">Certainty of evidence</h5> <p>We used the GRADE approach, as outlined in the <a href="http://gdt.guidelinedevelopment.org/central_prod/_design/client/handbook/handbook.html" target="_blank">GRADE Handbook</a> and <a href="./references#CD007137-bbs2-0051" title="SchünemannH , BrożekJ , GuyattG , OxmanA , editor(s), GRADE Working Group. Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). gdt.gradepro.org/app/handbook/handbook.html (accessed prior to 16 March 2020).">Schünemann 2013</a>, to assess the certainty of evidence for the following (clinically relevant) outcomes: any late‐onset sepsis, bacterial sepsis, fungal sepsis, all‐cause mortality, NEC ≥ stage II, chronic lung disease, threshold retinopathy of prematurity, length of hospital stay among survivors and duration of mechanical ventilation. </p> <p>Two review authors (MP, GS) independently assessed the certainty of evidence for each of the outcomes above. We considered evidence from RCTs as high certainty but downgraded the evidence one level for serious (or two levels for serious) limitations based on the following: design (risk of bias), consistency across studies, directness of the evidence, precision of estimates, and presence of asymmetry of the funnel plot (publication bias). We used the <a href="./references#CD007137-bbs2-0031" title="McMaster University (developed by Evidence Prime)GRADEpro GDT. Version accessed 9 March 2017. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. Available at gradepro.org.">GRADEpro GDT</a> Guideline Development Tool to create a 'Summary of findings' table to report the certainty of the evidence. </p> <p>The GRADE approach yields an assessment of the certainty of a body of evidence according to one of four grades. </p> <p> <ul id="CD007137-list-0006"> <li> <p>High: We are very confident that the true effect lies close to the estimate of effect.</p> </li> <li> <p>Moderate: We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of effect but may be substantially different. </p> </li> <li> <p>Low: Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of effect. </p> </li> <li> <p>Very low: We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </li> </ul> </p> </section> </section> <section id="CD007137-sec-0037"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Key subgroups were based on the following.</p> <p> <ol id="CD007137-list-0007"> <li> <p>Gestational age:</p> <ol id="CD007137-list-0008"> <li> <p>Preterm infants (32 to 36 weeks' gestational age)</p> </li> <li> <p>Preterm infants (&lt; 32 weeks' gestational age)</p> </li> </ol> </li> <li> <p>Birth weight:</p> <ol id="CD007137-list-0009"> <li> <p>VLBW infants (birth weight &lt; 1500 g)</p> </li> <li> <p>ELBW infants (birth weight &lt; 1000 g)</p> </li> </ol> </li> <li> <p>Feedings:</p> <ol id="CD007137-list-0010"> <li> <p>Breast milk feeding</p> </li> <li> <p>Formula feeding</p> </li> </ol> </li> </ol> </p> </section> <section id="CD007137-sec-0038"> <h4 class="title">Sensitivity analysis</h4> <p>We performed a post hoc sensitivity analysis by excluding studies of poor methodological certainty from the meta‐analysis for the outcome of late‐onset sepsis. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD007137-sec-0039" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD007137-sec-0039"></div> <section id="CD007137-sec-0040"> <h3 class="title">Description of studies</h3> <section id="CD007137-sec-0041"> <h4 class="title">Results of the search</h4> <p>Our search strategy yielded twelve randomized controlled trials (published in fourteen reports) that were eligible for inclusion (<a href="#CD007137-fig-0003">Figure 3</a>). Three published reports described one multicenter trial of enteral lactoferrin prophylaxis in preterm neonates (<a href="./references#CD007137-bbs2-0008" title="ManzoniP , MeyerM , StolfiI , RinaldiM , CattaniS , PugniL , et al. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial. Early Human Development2014;90 Suppl 1:S60-5. [DOI: 10.1016/S0378-3782(14)70020-9] [PMID: 24709463]ManzoniP , RinaldiM , CattaniS , PugniL , RomeoMG , MessnerH , et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA2009;302(13):1421-8. [DOI: 10.1001/jama.2009.1403] [PMID: DOI: 10.1001/jama.2009.1403; PubMed: 19809023]]ManzoniP , StolfiI , MessnerH , CattaniS , LaforgiaN , RomeoMG , et al. Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial. Pediatrics2012;129(1):116-23. [PMID: 10.1542/peds.2011-0279; PubMed: 22184648]]">Manzoni 2014</a>), and the other included studies enrolled preterm neonates from the United States (<a href="./references#CD007137-bbs2-0011" title="ShermanMP , AdamkinDH , NiklasV , RadmacherP , ShermanJ , WertheimerF , et al. Randomized controlled trial of talactoferrin oral solution in preterm infants. Journal of Pediatrics2016;175:68-73. [DOI: 10.1016/j.jpeds.2016.04.084] [PMID: 27260839]">Sherman 2016</a>), Turkey (<a href="./references#CD007137-bbs2-0001" title="AkinIM , AtasayB , DoguF , OkuluE , ArsanS , KaratasHD , et al. Oral lactoferrin to prevent nosocomial sepsis and necrotizing enterocolitis of premature neonates and effect on T-regulatory cells. American Journal of Perinatology2014;31(12):1111-20. [DOI: 10.1055/s-0034-1371704] [PMID: 24839144] [PMID: 24839144]">Akin 2014</a>), Canada (<a href="./references#CD007137-bbs2-0002" title="BarringtonKJ , AssaadMA , JanvierA . The Lacuna Trial: a double-blind randomized controlled pilot trial of lactoferrin supplementation in the very preterm infant. Journal of Perinatology2016;36(8):666-9. [DOI: 10.1038/jp.2016.24] [PMID: 26938920] [PMID: 26938920]">Barrington 2016</a>), India (<a href="./references#CD007137-bbs2-0005" title="KaurG , GathwalaG . Efficacy of bovine lactoferrin supplementation in preventing late-onset sepsis in low birth weight neonates: a randomized placebo-controlled clinical trial. Journal of Tropical Pediatrics2015;61(5):370-6. [DOI: 10.1093/tropej/fmv044] [PMID: 26224129]">Kaur 2015</a>), Peru (<a href="./references#CD007137-bbs2-0009" title="OchoaTJ , ZegarraJ , CamL , LlanosR , PezoA , CruzK , et al. Randomized controlled trial of lactoferrin for prevention of sepsis in Peruvian neonates less than 2500 g. Pediatric Infectious Disease Journal2015;34(6):571-6. [DOI: 10.1097/INF.0000000000000593] [PMID: 25973934]">Ochoa 2015</a>, <a href="./references#CD007137-bbs2-0010" title="OchoaT , ZegarraJ , BellomoS , CarcamoC , CamL , CastanedaA , et al, Neolacto Research Group. Randomized controlled trial of bovine lactoferrin for prevention of sepsis and neurodevelopmental impairment in infants weighing less than 2000 grams. Journal of Pediatrics (in press) 2020. ">Ochoa 2020</a>), United Kingdom (<a href="./references#CD007137-bbs2-0004" title="ISRCTN88261002. Enteral lactoferrin supplementation for very preterm infants: a randomised controlled trial. isrctn.com/ISRCTN88261002 (first received 5 June 2013). [DOI: 10.1186/ISRCTN88261002]">ELFIN 2018</a>), Australia and New Zealand (<a href="./references#CD007137-bbs2-0006" title="Tarnow-MordiWO , Abdel-LatifME , MartinA , PammiM , RobledoK , ManzoniP , et al, LIFT collaborators. The Lactoferrin Infant Feeding Trial (LIFT): a pragmatic, randomised, multicentre study in very low birth weight infants. Lancet. Child and Adolescent Health.2020;4(6):444-54 (with online Supplementary Appendix pp S1-44). [DOI: 10.1016/S2352-4642(20)30093-6]">LIFT 2020</a>) and China (<a href="./references#CD007137-bbs2-0003" title="DaiJZ , XieC . The effect of lactoferrin supplementation combining Lactobacillus rhamnosus for prevention of late onset sepsis in premature neonates. China Practical Medicine2015;10:98-100. ">Dai 2015</a>; <a href="./references#CD007137-bbs2-0007" title="LiuYH , GuanHS , LiangGJ , LiYZ , ZuoA . The effect of lactoferrin on low birth weight neonates during hospitalization. Maternal and Child Health Care of China2016;31(21):4464-5. ">Liu 2016</a>; <a href="./references#CD007137-bbs2-0012" title="TangJP , SunHQ , ZhengYH , LuGH . Randomized control trial of lactoferrin for the prevention of late onset sepsis in premature neonates. Maternal and Child Health Care of China2017;32(6):1223-5. ">Tang 2017</a>). Refer to the <a href="./references#CD007137-sec-0112" title="">Characteristics of included studies</a> table for details. </p> <div class="figure" id="CD007137-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Study flow diagram for the updated search in January 20, 2020" data-id="CD007137-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-FIG-03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram for the updated search in January 20, 2020</p> </div> </div> </div> </section> <section id="CD007137-sec-0042"> <h4 class="title">Included studies</h4> <p><a href="./references#CD007137-bbs2-0008" title="ManzoniP , MeyerM , StolfiI , RinaldiM , CattaniS , PugniL , et al. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial. Early Human Development2014;90 Suppl 1:S60-5. [DOI: 10.1016/S0378-3782(14)70020-9] [PMID: 24709463]ManzoniP , RinaldiM , CattaniS , PugniL , RomeoMG , MessnerH , et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA2009;302(13):1421-8. [DOI: 10.1001/jama.2009.1403] [PMID: DOI: 10.1001/jama.2009.1403; PubMed: 19809023]]ManzoniP , StolfiI , MessnerH , CattaniS , LaforgiaN , RomeoMG , et al. Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial. Pediatrics2012;129(1):116-23. [PMID: 10.1542/peds.2011-0279; PubMed: 22184648]]">Manzoni 2014</a> </p> <p>This study consisted of 3 separate reports published by the investigators in 2009, 2012 and 2014. </p> <p><b>Manzoni 2009:</b> Manzoni and coworkers randomly assigned VLBW infants (birth weight &lt; 1500 g) in 11 Italian NICUs to enteral bovine lactoferrin alone or in combination with a probiotic (<i>Lactobacillus rhamnosus</i> GG) or to placebo. The study enrolled neonates from Oct 1, 2007 to July 31, 2008. Late‐onset sepsis, defined as isolation of a pathogen in the blood, peritoneal fluid, or CSF after three days of life, was the primary outcome of interest. Secondary outcomes assessed included gram‐positive, gram‐negative, or fungal sepsis; mortality before hospital discharge; urinary tract infection; fungal colonization; progression from fungal colonization to invasive fungal infection; bronchopulmonary dysplasia (BPD); severe intraventricular hemorrhage (grade III or IV); threshold retinopathy of prematurity (ROP); NEC ≥ stage II; alteration of liver functions; and adverse effects. </p> <p><b>Manzoni 2012:</b> This report presented the secondary analysis of data from the <b>Manzoni 2009</b> report pertaining to fungal colonization and invasive fungal infections. Interventions and patient populations were similar to those in the Manzoni 2009 study. Prophylaxis with antifungal drugs was an exclusion criterion which was not permitted by the study protocol. Primary outcomes assessed were incidence rates of fungal colonization and invasive fungal infection. Secondary outcomes included intensity of fungal colonization, rate of progression to infection in colonized infants, frequencies of single fungal species in all groups, and mortality related to invasive fungal infections. </p> <p><b>Report published in 2014:</b> This continuation of a randomized trial (<b>Manzoni 2009</b>) was conducted to enhance power for assessing effects of enteral bovine lactoferrin in prevention of NEC. Thirteen neonatal intensive care units (NICUs) in Italy and New Zealand participated and enrolled neonates from October 1, 2007 through July 31, 2010. Interventions and patient populations and outcomes were similar to those included in the Manzoni 2009 study. </p> <p><a href="./references#CD007137-bbs2-0001" title="AkinIM , AtasayB , DoguF , OkuluE , ArsanS , KaratasHD , et al. Oral lactoferrin to prevent nosocomial sepsis and necrotizing enterocolitis of premature neonates and effect on T-regulatory cells. American Journal of Perinatology2014;31(12):1111-20. [DOI: 10.1055/s-0034-1371704] [PMID: 24839144] [PMID: 24839144]">Akin 2014</a> </p> <p>This prospective, single‐centre, double‐blind, randomized controlled trial was performed at Ankara University, Turkey, between December 2009 and January 2011. Investigators randomly assigned inborn neonates born at &lt; 1500 g or at gestational age &lt; 32 weeks to bovine lactoferrin (200 mg/d) or placebo (2 mL of saline), once a day until discharge. Exclusion criteria were lack of parental consent, severe congenital malformations, severe hypoxic‐ischemic encephalopathy (HIE), and death before 72 hours of life. Primary outcomes assessed were nosocomial sepsis as defined by criteria of the Centers for Disease Control and Prevention and NEC stage II. Secondary outcomes included safety (feeding tolerance, abdominal distention, emesis, and gastric residuals), length of hospital stay, and maturation of regulatory T‐cell (Treg) levels. </p> <p><a href="./references#CD007137-bbs2-0009" title="OchoaTJ , ZegarraJ , CamL , LlanosR , PezoA , CruzK , et al. Randomized controlled trial of lactoferrin for prevention of sepsis in Peruvian neonates less than 2500 g. Pediatric Infectious Disease Journal2015;34(6):571-6. [DOI: 10.1097/INF.0000000000000593] [PMID: 25973934]">Ochoa 2015</a> </p> <p>Ochoa and coworkers enrolled 190 preterm infants &lt; 2500 g in five neonatal intermediate and intensive care units in Lima, Peru, who were admitted to the NICU during the first 72 hours of life. Researchers randomly assigned neonates to oral bovine lactoferrin (200 mg/kg/d divided into three doses) or to oral maltodextrin (200 mg/kg/d in three divided doses) for four weeks; they dissolved both in human milk or formula or in 5% glucose solution. The primary outcome assessed was the number of confirmed episodes of late‐onset sepsis in the first month of life; secondary outcomes assessed were incidence of gram‐positive and gram‐negative bacterial sepsis, fungal sepsis, pneumonia, diarrhea, and mortality in the first month of life. </p> <p><a href="./references#CD007137-bbs2-0011" title="ShermanMP , AdamkinDH , NiklasV , RadmacherP , ShermanJ , WertheimerF , et al. Randomized controlled trial of talactoferrin oral solution in preterm infants. Journal of Pediatrics2016;175:68-73. [DOI: 10.1016/j.jpeds.2016.04.084] [PMID: 27260839]">Sherman 2016</a> </p> <p>This randomized clinical trial of human recombinant lactoferrin (talactoferrin (TLF)) conducted in the United States enrolled a total of 120 neonates (60 in each group). Investigators randomly assigned preterm infants with birth weight of 750 to 1500 g to enteral TLF or to placebo from 1 to 29 days of life at a dose of 150 mg/kg every 12 hours (TLF was provided by Agennix, Inc.). Primary outcomes assessed were bacteremia, meningitis, pneumonia, urinary tract infection, and necrotizing enterocolitis; secondary outcomes were sepsis syndrome and suspected NEC. </p> <p><a href="./references#CD007137-bbs2-0002" title="BarringtonKJ , AssaadMA , JanvierA . The Lacuna Trial: a double-blind randomized controlled pilot trial of lactoferrin supplementation in the very preterm infant. Journal of Perinatology2016;36(8):666-9. [DOI: 10.1038/jp.2016.24] [PMID: 26938920] [PMID: 26938920]">Barrington 2016</a> </p> <p>This randomized controlled trial of oral bovine lactoferrin in Montreal, Canada enrolled 79 neonates between January 2011 and April 2013. Investigators randomly assigned preterm infants in the NICU at CHU Sainte Justine, with a gestational age at birth between 23 0/7 and 30 6/7 weeks, who were less than 48 hours of age, to oral lactoferrin or placebo. The exclusion criterion was the presence of intestinal abnormalities that would prevent enteral feeding, such as gastroschisis. The intervention group received 100 mg per day of bovine lactoferrin, divided into two doses per day, starting on the first day of enteral feeding (day of enrollment) or at the latest at 48 hours of age and until 36 weeks' PMA or discharge home. The control group received milk without lactoferrin. The primary outcome assessed was feeding tolerance, defined as the length of time required to achieve 140 mL/kg/d; secondary outcomes were death, late‐onset sepsis, combined variable of death or late‐onset sepsis, NEC stage II or III, duration of total parenteral nutrition (TPN), number of times made nil by mouth, growth variables at discharge, ROP, and BPD. </p> <p><a href="./references#CD007137-bbs2-0005" title="KaurG , GathwalaG . Efficacy of bovine lactoferrin supplementation in preventing late-onset sepsis in low birth weight neonates: a randomized placebo-controlled clinical trial. Journal of Tropical Pediatrics2015;61(5):370-6. [DOI: 10.1093/tropej/fmv044] [PMID: 26224129]">Kaur 2015</a> </p> <p>This trial randomized inborn neonates with birth weight less than 2000 g, who had no maternal risk factors for sepsis, to bovine lactoferrin or to placebo from day 1 to day 28 of life. The dose of lactoferrin ranged from 100 to 250 mg and was based on birth weight. Criteria for exclusion were congenital anomalies, severe birth asphyxia, history of maternal chorioamnionitis, suspected congenital infection, and family history of cow's milk allergy. Neonates with culture‐proven early‐onset sepsis were also excluded. The primary outcome was culture‐proven late‐onset sepsis. Secondary outcome measures were probable late‐onset sepsis, any late‐onset sepsis, and sepsis‐attributed mortality. </p> <p><a href="./references#CD007137-bbs2-0003" title="DaiJZ , XieC . The effect of lactoferrin supplementation combining Lactobacillus rhamnosus for prevention of late onset sepsis in premature neonates. China Practical Medicine2015;10:98-100. ">Dai 2015</a> </p> <p>This randomized trial in Puning, China, enrolled 105 very low birth weight infants between October 2010 and May 2014. The average gestational age was 30 weeks. The study investigated the effects of lactoferrin (100 mg/d) or lactoferrin plus probiotic LGG, comparing with control group (placebo). The primary outcome assessed was late‐onset sepsis and the secondary outcomes were the infection markers C‐reactive protein (CRP) and procalcitonin (PCT). </p> <p><a href="./references#CD007137-bbs2-0007" title="LiuYH , GuanHS , LiangGJ , LiYZ , ZuoA . The effect of lactoferrin on low birth weight neonates during hospitalization. Maternal and Child Health Care of China2016;31(21):4464-5. ">Liu 2016</a> </p> <p>This randomized controlled trial, of oral bovine lactoferrin in Guangzhou, China, enrolled 257 infants between January 2013 and December 2015. Investigators randomly assigned preterm infants who were less than 72 hours of age into a control group, lactoferrin group, and lactoferrin plus probiotic LGG group. The exclusion criteria were congenital anomaly of digestive tract, respiratory distress more than three days, and discharge without medical advice. The intervention group received 125 mg/dose, 2 doses per day of bovine lactoferrin. The control group received the same volume of water with glucose (placebo). The primary outcomes assessed were late‐onset sepsis, NEC, mortality during hospitalization, and length of hospital stay. </p> <p><a href="./references#CD007137-bbs2-0012" title="TangJP , SunHQ , ZhengYH , LuGH . Randomized control trial of lactoferrin for the prevention of late onset sepsis in premature neonates. Maternal and Child Health Care of China2017;32(6):1223-5. ">Tang 2017</a> </p> <p>This randomized controlled trial of oral bovine lactoferrin in Zhengzhou, China, enrolled 160 infants between March 2013 and June 2014. Investigators randomly assigned low birth weight infants (26‐36 weeks' gestational age) to lactoferrin or control groups at less than 72 hours of age. The exclusion criteria were infants receiving antifungal medications, early‐onset sepsis (within three days), and hepatic failure. The lactoferrin intervention group received 100 mg/d of bovine lactoferrin. The control group received the same volume of water with 5% glucose (placebo). The primary outcomes assessed were late‐onset sepsis, all‐cause mortality, and sepsis‐related mortality during hospitalization. </p> <p><a href="./references#CD007137-bbs2-0004" title="ISRCTN88261002. Enteral lactoferrin supplementation for very preterm infants: a randomised controlled trial. isrctn.com/ISRCTN88261002 (first received 5 June 2013). [DOI: 10.1186/ISRCTN88261002]">ELFIN 2018</a> </p> <p>This multicenter, randomized, placebo‐controlled trial conducted in the United Kingdom examined prophylactic enteral lactoferrin supplementation to prevent late‐onset invasive infection in very preterm infants. The investigators enrolled 2203 participants between May 2014 to September 2017. Infants are eligible to participate if gestational age at birth was &lt; 32 weeks', if they were &lt; 72 hours old, and if written informed parental consent was obtained. Researchers randomly assigned infants to receive lactoferrin (150 mg/kg/d to a maximum of 300 mg) or placebo once daily until 34 completed weeks' post‐menstrual age. Primary outcomes assessed included the incidence of microbiologically confirmed or clinically suspected late‐onset infection from trial entry until hospital discharge. Secondary outcomes included 'all‐cause mortality' before hospital discharge; necrotizing enterocolitis (NEC) Bell’s stage II or III; severe ROP treated medically or surgically; BPD; a composite of invasive infection, major morbidity (NEC, ROP, or BPD), and mortality; number of days of administration of antibiotics per infant from 72 hours until death or discharge from hospital; number of days of administration of antifungal agents per infant; and length of hospital stay. This study was coordinated by the National Perinatal Epidemiology Unit Clinical Trials Unit, at the University of Oxford, UK. We thank Dr. William McGuire from the trial investigator group for providing data for inclusion in this systematic review. </p> <p><a href="./references#CD007137-bbs2-0006" title="Tarnow-MordiWO , Abdel-LatifME , MartinA , PammiM , RobledoK , ManzoniP , et al, LIFT collaborators. The Lactoferrin Infant Feeding Trial (LIFT): a pragmatic, randomised, multicentre study in very low birth weight infants. Lancet. Child and Adolescent Health.2020;4(6):444-54 (with online Supplementary Appendix pp S1-44). [DOI: 10.1016/S2352-4642(20)30093-6]">LIFT 2020</a> </p> <p>The Lactoferrin Infant Feeding Trial (LIFT) to prevent sepsis and death in preterm infants was a double‐blind, randomized, controlled trial conducted in Australia and New Zealand. Eligibility for inclusion was based on the following: (1) doctor and parents are substantially uncertain whether bovine lactoferrin (BLF) is indicated or contraindicated, (2) &lt; 1500 g birth weight, (3) &lt; 7 days old, and (4) written informed consent from the parent. Researchers randomly assigned neonates to BLF at 200 mg/kg/d dissolved in breast milk or formula until 34 weeks' corrected gestational age or hospital discharge or to placebo (breast milk or formula (without BLF)). The primary outcome was mortality or major morbidity before hospital discharge. Morbidity was defined as the diagnosis of sepsis, brain injury, chronic lung disease, necrotizing enterocolitis, or severe retinopathy. Secondary outcomes assessed included mortality related to sepsis (as assessed by positive blood culture). The trial was registered as ACTRN12611000247976. </p> <p><a href="./references#CD007137-bbs2-0010" title="OchoaT , ZegarraJ , BellomoS , CarcamoC , CamL , CastanedaA , et al, Neolacto Research Group. Randomized controlled trial of bovine lactoferrin for prevention of sepsis and neurodevelopmental impairment in infants weighing less than 2000 grams. Journal of Pediatrics (in press) 2020. ">Ochoa 2020</a> </p> <p>This was a phase 3 randomized controlled trial of oral lactoferrin for prevention of sepsis in infants (NEOLACTO study) conducted in Lima, Peru. Neonates with birth weight between 500 g and 2000 g and born in or referred to the neonatal unit of one of the participating hospitals during the first 72 hours of life were eligible. Investigators randomly assigned preterm neonates to oral bovine lactoferrin (200 mg/kg/d divided in three doses) or oral maltodextrin (200 mg/kg/d in three divided doses) for eight weeks. The primary outcome assessed was a composite outcome of first episode of late‐onset sepsis or sepsis‐associated death. The secondary outcome was neurodevelopment at 24 months' corrected age assessed by the Mullen Scale for Early Learning and Bayley III. The trial was registered as NCT01525316. </p> </section> <section id="CD007137-sec-0043"> <h4 class="title">Excluded studies</h4> <p><a href="./references#CD007137-bbs2-0013" title="King JC Jr, CummingsGE , GuoN , TrivediL , ReadmondBX , KeaneV , et al. A double-blind, placebo-controlled, pilot study of bovine lactoferrin supplementation in bottle-fed infants. Journal of Pediatric Gastroenterology and Nutrition2007;44(2):245-51. [DOI: 10.1097/01.mpg.0000243435.54958.68] [PMID: 17255839]">King 2007</a> </p> <p>Investigators enrolled healthy, formula‐fed infants at 34 weeks' gestation or later and at four weeks of age or younger from a pediatric clinic. Infants received formula supplemented with lactoferrin (850 mg/L) or commercial cow's milk‐based formula (102 mg/L) for 12 months. Researchers collected growth parameters and information on gastrointestinal, respiratory, and colic illnesses for the infants' first year. Review authors excluded this study, as most enrolled infants were beyond the neonatal period and trial authors did not assess our prespecified neonatal outcomes. </p> <p><a href="./references#CD007137-bbs2-0015" title="OchoaT , Chea-WooE , BaiocchiN , PechoI , CamposM , PradaA , et al. Randomized double-blind controlled trial of bovine lactoferrin for prevention of diarrhea in children. Journal of Pediatrics2013;162(2):349–56. [DOI: 10.1016/j.jpeds.2012.07.043] [PMID: 22939927]">Ochoa 2013</a> </p> <p>This community‐based, randomized, double‐blind, placebo‐controlled trial compared supplementation with bovine lactoferrin versus placebo. Investigators randomly assigned 577 weaned children at 12 to 18 months and followed them for six months with daily home visits. Treatment was given to prevent diarrhea, and outcomes assessed included number of diarrheal episodes, longitudinal prevalence of diarrhea, and severity of diarrhea and dehydration. Review authors excluded this study, as participants were not neonates. </p> <p><a href="./references#CD007137-bbs2-0014" title="MeyerMP , AlexanderT . Reduction in necrotizing enterocolitis and improved outcomes in preterm infants following routine supplementation with lactobacillus GG in combination with bovine lactoferrin. Journal of Neonatal-Perinatal Medicine2016;10(3):249-55. [DOI: 10.3233/NPM-16130] [PMID: 28854514]">Meyer 2016</a> </p> <p>This nonrandomized, retrospective, observational study compared the lactoferrin prophylaxis cohort (during the years 2004‐2011) with an historical cohort without lactoferrin prophylaxis (during the years 2001‐2004). The prophylaxis cohort received 100 mg of bovine lactoferrin and a probiotic. This conference abstract reported rates of NEC, late‐onset sepsis, and ROP treatment. Review authors excluded this study because it was a nonrandomized study. </p> <section id="CD007137-sec-0044"> <h5 class="title">Studies awaiting classification</h5> <p><a href="./references#CD007137-bbs2-0017" title="NCT01172236. Supplementation with lactoferrin in preterm newborns (lactoprenew). clinicaltrials.gov/show/NCT01172236 (first received 29 July 2010). ">NCT01172236</a> </p> <p>This randomized controlled trial of lactoferrin supplementation included preterm infants with birth weight ≤ 1500 g and/or gestational age ≤ 32 weeks. The study excluded neonates if fetal‐onset disorders were recognizable at birth, and if milk intolerance, family history of allergy, and use of infant formula supplemented with lactoferrin were reported. The intervention group (n = 650) received a daily dose of 100 mg of lactoferrin, and the control group (n = 650) received only standard therapy. Primary outcomes to be assessed were antioxidant effects of lactoferrin and its ability to reduce free radical‐related diseases in the newborn; these were assessed through neurodevelopmental follow‐up. The secondary outcome was identification of a panel of markers for assessment of oxidative stress and for correlation with the lactoferrin antioxidant effect. This study planned to enroll 1300 neonates starting January 2011. We have re‐requested details of the study from the principal investigator. </p> <p><a href="./references#CD007137-bbs2-0016" title="ISRCTN71737811. Effect of prebiotic or lactoferrin supplementation in formula on the gut flora of preterm infants. isrctn.com/ISRCTN71737811 (first received 5 September 2008). ">ISRCTN71737811</a> </p> <p>This was a prospective, double‐blind, randomized, placebo‐controlled study of preterm infants (n = 60) with gestational age 26 ± 0 to 35 ± 6 weeks. Researchers excluded neonates if born weighing &lt; 600 g, or if they had life‐threatening congenital malformations, non‐Dutch or non‐English‐speaking parents, or a history of allergy among parents or siblings. Trial investigators randomly assigned infants to standard preterm formula, standard preterm formula with probiotics (galacto‐oligosaccharides 28.5%, lactose 9.5%, galactose 0.5%, minerals 3.5%, fat 1.5%, and water 3%), or standard preterm formula with dairy lactoferrin 1 mg/100 mL (n = 20 in each group). The primary outcome assessed was composition of the gut flora at six weeks of full enteral feeds, incidence of infection, oxidative stress, and iron status. Secondary outcomes assessed were growth (weight, length, and head circumference), feeding intolerance, and psychomotor development at one year of age. This unpublished study was completed in 2009. We have re‐requested details of the study from the principal investigator. </p> <p><a href="./references#CD007137-bbs2-0018" title="NCT02959229. Early versus late lactoferrin in prevention of neonatal sepsis [Systematic randomized, single blinded, placebo-controlled trial of early versus late lactoferrin in prevention of neonatal sepsis]. clinicaltrials.gov/show/NCT02959229 (first received 27 October 2016). ">NCT02959229</a> </p> <p>This completed randomized controlled study enrolled 180 preterm neonates (&lt; 37 weeks' gestation counting from the first day of the last menstrual period and confirmed by Ballard score) admitted to the NICUs of Ain Shams University Hospitals during the period from August 2014 to December 2015. Researchers further randomly subdivided enrolled participants into three groups according to the dose regimen of lactoferrin supplementation: Group A (60 preterm neonates) received oral lactoferrin supplementation at a dose of 100 mg/d starting on day 1 and continuing for four to six weeks; Group B (60 preterm neonates) received oral lactoferrin supplementation at a dose of 100 mg/d starting on day 3 (48 to 72 hours) of life and continuing for four to six weeks; and Group C (60 preterm neonates) who received placebo in the form of distilled water. Primary outcomes included evaluation of the effectiveness of oral lactoferrin in preventing neonatal sepsis according to Tollner score, haematological scoring system (HSS), and positive blood culture.over four to six weeks of life. Secondary outcomes included evaluation of the effects of lactoferrin supplementation on long‐term complications of BPD (defined by clinical symptoms and signs and chest X‐ray findings), ROP (as defined by the International Classification of Retinopathy of Prematurity (ICROP)), NEC (defined by Modified Bell's criteria), and any reported side effects for bovine lactoferrin. The trial was completed in October 2016. We have re‐requested details of the study from the principal investigator without response. </p> </section> <section id="CD007137-sec-0045"> <h5 class="title">Ongoing studies</h5> <p><a href="./references#CD007137-bbs2-0019" title="NCT01821989. Oral lactoferrin supplementation for prevention of sepsis in preterm neonate. clinicaltrials.gov/show/NCT01821989 (first received 27 March 2013). ">NCT01821989</a> </p> <p>This double‐blind, randomized, controlled trial included neonates weighing between 500 g and 2500 g and at ≤ 36 weeks' gestation, who were born in or were referred to the NICU of one of the participating hospitals during the first 48 hours of life. Investigators randomly assigned preterm neonates to one of three groups: low‐dose lactoferrin (100 mg/d), high‐dose lactoferrin (150 mg/kg/twice daily), or placebo (distilled water). The primary outcome assessed was blood culture positivity; secondary outcomes were complete blood count with differential leukocyte count and C‐reactive protein quantitative assay. This study was scheduled to start in June 2013 and planned to enroll 180 preterm neonates through January 2016. We have re‐requested details of the study from the principal investigator without response. </p> </section> </section> </section> <section id="CD007137-sec-0046"> <h3 class="title">Risk of bias in included studies</h3> <p>A 'Risk of bias' summary and graph are reported in <a href="#CD007137-fig-0004">Figure 4</a>; and <a href="#CD007137-fig-0005">Figure 5</a>. </p> <div class="figure" id="CD007137-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD007137-fig-0004" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-FIG-04.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD007137-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD007137-fig-0005" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-FIG-05.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD007137-sec-0047"> <h4 class="title">Allocation</h4> <p>In the multicenter trial of <a href="./references#CD007137-bbs2-0008" title="ManzoniP , MeyerM , StolfiI , RinaldiM , CattaniS , PugniL , et al. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial. Early Human Development2014;90 Suppl 1:S60-5. [DOI: 10.1016/S0378-3782(14)70020-9] [PMID: 24709463]ManzoniP , RinaldiM , CattaniS , PugniL , RomeoMG , MessnerH , et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA2009;302(13):1421-8. [DOI: 10.1001/jama.2009.1403] [PMID: DOI: 10.1001/jama.2009.1403; PubMed: 19809023]]ManzoniP , StolfiI , MessnerH , CattaniS , LaforgiaN , RomeoMG , et al. Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial. Pediatrics2012;129(1):116-23. [PMID: 10.1542/peds.2011-0279; PubMed: 22184648]]">Manzoni 2014</a>, investigators stratified randomization by centre and generated randomization sequences by using computer software. The pharmacy at each centre prepared the interventions and diluted them in milk feeds on the basis of randomization sequence. <a href="./references#CD007137-bbs2-0001" title="AkinIM , AtasayB , DoguF , OkuluE , ArsanS , KaratasHD , et al. Oral lactoferrin to prevent nosocomial sepsis and necrotizing enterocolitis of premature neonates and effect on T-regulatory cells. American Journal of Perinatology2014;31(12):1111-20. [DOI: 10.1055/s-0034-1371704] [PMID: 24839144] [PMID: 24839144]">Akin 2014</a>; <a href="./references#CD007137-bbs2-0003" title="DaiJZ , XieC . The effect of lactoferrin supplementation combining Lactobacillus rhamnosus for prevention of late onset sepsis in premature neonates. China Practical Medicine2015;10:98-100. ">Dai 2015</a>; <a href="./references#CD007137-bbs2-0007" title="LiuYH , GuanHS , LiangGJ , LiYZ , ZuoA . The effect of lactoferrin on low birth weight neonates during hospitalization. Maternal and Child Health Care of China2016;31(21):4464-5. ">Liu 2016</a>; and <a href="./references#CD007137-bbs2-0012" title="TangJP , SunHQ , ZhengYH , LuGH . Randomized control trial of lactoferrin for the prevention of late onset sepsis in premature neonates. Maternal and Child Health Care of China2017;32(6):1223-5. ">Tang 2017</a> did not report random sequence generation nor allocation concealment. <a href="./references#CD007137-bbs2-0011" title="ShermanMP , AdamkinDH , NiklasV , RadmacherP , ShermanJ , WertheimerF , et al. Randomized controlled trial of talactoferrin oral solution in preterm infants. Journal of Pediatrics2016;175:68-73. [DOI: 10.1016/j.jpeds.2016.04.084] [PMID: 27260839]">Sherman 2016</a> randomly assigned enrolled neonates centrally using a permuted block method. <a href="./references#CD007137-bbs2-0002" title="BarringtonKJ , AssaadMA , JanvierA . The Lacuna Trial: a double-blind randomized controlled pilot trial of lactoferrin supplementation in the very preterm infant. Journal of Perinatology2016;36(8):666-9. [DOI: 10.1038/jp.2016.24] [PMID: 26938920] [PMID: 26938920]">Barrington 2016</a>; <a href="./references#CD007137-bbs2-0004" title="ISRCTN88261002. Enteral lactoferrin supplementation for very preterm infants: a randomised controlled trial. isrctn.com/ISRCTN88261002 (first received 5 June 2013). [DOI: 10.1186/ISRCTN88261002]">ELFIN 2018</a>; <a href="./references#CD007137-bbs2-0005" title="KaurG , GathwalaG . Efficacy of bovine lactoferrin supplementation in preventing late-onset sepsis in low birth weight neonates: a randomized placebo-controlled clinical trial. Journal of Tropical Pediatrics2015;61(5):370-6. [DOI: 10.1093/tropej/fmv044] [PMID: 26224129]">Kaur 2015</a>; <a href="./references#CD007137-bbs2-0006" title="Tarnow-MordiWO , Abdel-LatifME , MartinA , PammiM , RobledoK , ManzoniP , et al, LIFT collaborators. The Lactoferrin Infant Feeding Trial (LIFT): a pragmatic, randomised, multicentre study in very low birth weight infants. Lancet. Child and Adolescent Health.2020;4(6):444-54 (with online Supplementary Appendix pp S1-44). [DOI: 10.1016/S2352-4642(20)30093-6]">LIFT 2020</a>; <a href="./references#CD007137-bbs2-0009" title="OchoaTJ , ZegarraJ , CamL , LlanosR , PezoA , CruzK , et al. Randomized controlled trial of lactoferrin for prevention of sepsis in Peruvian neonates less than 2500 g. Pediatric Infectious Disease Journal2015;34(6):571-6. [DOI: 10.1097/INF.0000000000000593] [PMID: 25973934]">Ochoa 2015</a> and <a href="./references#CD007137-bbs2-0010" title="OchoaT , ZegarraJ , BellomoS , CarcamoC , CamL , CastanedaA , et al, Neolacto Research Group. Randomized controlled trial of bovine lactoferrin for prevention of sepsis and neurodevelopmental impairment in infants weighing less than 2000 grams. Journal of Pediatrics (in press) 2020. ">Ochoa 2020</a> had low risk of selection bias, as researchers reported adequate randomization and allocation concealment methods. </p> </section> <section id="CD007137-sec-0048"> <h4 class="title">Blinding</h4> <p><a href="./references#CD007137-bbs2-0008" title="ManzoniP , MeyerM , StolfiI , RinaldiM , CattaniS , PugniL , et al. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial. Early Human Development2014;90 Suppl 1:S60-5. [DOI: 10.1016/S0378-3782(14)70020-9] [PMID: 24709463]ManzoniP , RinaldiM , CattaniS , PugniL , RomeoMG , MessnerH , et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA2009;302(13):1421-8. [DOI: 10.1001/jama.2009.1403] [PMID: DOI: 10.1001/jama.2009.1403; PubMed: 19809023]]ManzoniP , StolfiI , MessnerH , CattaniS , LaforgiaN , RomeoMG , et al. Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial. Pediatrics2012;129(1):116-23. [PMID: 10.1542/peds.2011-0279; PubMed: 22184648]]">Manzoni 2014</a> investigators diluted interventions in feeds and blinded clinical and research staff to the intervention. Blinding of clinicians was not adequately reported in <a href="./references#CD007137-bbs2-0003" title="DaiJZ , XieC . The effect of lactoferrin supplementation combining Lactobacillus rhamnosus for prevention of late onset sepsis in premature neonates. China Practical Medicine2015;10:98-100. ">Dai 2015</a>; <a href="./references#CD007137-bbs2-0007" title="LiuYH , GuanHS , LiangGJ , LiYZ , ZuoA . The effect of lactoferrin on low birth weight neonates during hospitalization. Maternal and Child Health Care of China2016;31(21):4464-5. ">Liu 2016</a>; or <a href="./references#CD007137-bbs2-0012" title="TangJP , SunHQ , ZhengYH , LuGH . Randomized control trial of lactoferrin for the prevention of late onset sepsis in premature neonates. Maternal and Child Health Care of China2017;32(6):1223-5. ">Tang 2017</a>. Other included studies reported blinding of caregivers and were at low risk for performance bias. </p> <p>None of the included studies except <a href="./references#CD007137-bbs2-0001" title="AkinIM , AtasayB , DoguF , OkuluE , ArsanS , KaratasHD , et al. Oral lactoferrin to prevent nosocomial sepsis and necrotizing enterocolitis of premature neonates and effect on T-regulatory cells. American Journal of Perinatology2014;31(12):1111-20. [DOI: 10.1055/s-0034-1371704] [PMID: 24839144] [PMID: 24839144]">Akin 2014</a>, <a href="./references#CD007137-bbs2-0004" title="ISRCTN88261002. Enteral lactoferrin supplementation for very preterm infants: a randomised controlled trial. isrctn.com/ISRCTN88261002 (first received 5 June 2013). [DOI: 10.1186/ISRCTN88261002]">ELFIN 2018</a> and <a href="./references#CD007137-bbs2-0006" title="Tarnow-MordiWO , Abdel-LatifME , MartinA , PammiM , RobledoK , ManzoniP , et al, LIFT collaborators. The Lactoferrin Infant Feeding Trial (LIFT): a pragmatic, randomised, multicentre study in very low birth weight infants. Lancet. Child and Adolescent Health.2020;4(6):444-54 (with online Supplementary Appendix pp S1-44). [DOI: 10.1016/S2352-4642(20)30093-6]">LIFT 2020</a> explicitly reported blinding of outcome assessment. </p> </section> <section id="CD007137-sec-0049"> <h4 class="title">Incomplete outcome data</h4> <p>Researchers in included studies assessed outcomes at hospital discharge and adequately accounted for incomplete data. In the study of <a href="./references#CD007137-bbs2-0010" title="OchoaT , ZegarraJ , BellomoS , CarcamoC , CamL , CastanedaA , et al, Neolacto Research Group. Randomized controlled trial of bovine lactoferrin for prevention of sepsis and neurodevelopmental impairment in infants weighing less than 2000 grams. Journal of Pediatrics (in press) 2020. ">Ochoa 2020</a>, 25% of infants did not have a neurodevelopmental exam at 24 months either due to death or dropout. </p> </section> <section id="CD007137-sec-0050"> <h4 class="title">Selective reporting</h4> <p>None of the included studies revealed selective outcome reporting or other biases.</p> </section> </section> <section id="CD007137-sec-0051"> <h3 class="title" id="CD007137-sec-0051">Effects of interventions</h3> <p>See: <a href="./full#CD007137-tbl-0001"><b>Summary of findings 1</b> Lactoferrin supplementation compared to control for very low birth weight infants</a>; <a href="./full#CD007137-tbl-0002"><b>Summary of findings 2</b> Lactoferrin supplementation with enteral feeds in combination with probiotics compared to placebo for prevention of sepsis and necrotizing enterocolitis in preterm infants</a> </p> <section id="CD007137-sec-0052"> <h4 class="title">Lactoferrin supplementation of enteral feeds versus placebo (comparison 1)</h4> <p>All twelve included trials provided outcome data for this comparison (<a href="./references#CD007137-bbs2-0001" title="AkinIM , AtasayB , DoguF , OkuluE , ArsanS , KaratasHD , et al. Oral lactoferrin to prevent nosocomial sepsis and necrotizing enterocolitis of premature neonates and effect on T-regulatory cells. American Journal of Perinatology2014;31(12):1111-20. [DOI: 10.1055/s-0034-1371704] [PMID: 24839144] [PMID: 24839144]">Akin 2014</a>; <a href="./references#CD007137-bbs2-0002" title="BarringtonKJ , AssaadMA , JanvierA . The Lacuna Trial: a double-blind randomized controlled pilot trial of lactoferrin supplementation in the very preterm infant. Journal of Perinatology2016;36(8):666-9. [DOI: 10.1038/jp.2016.24] [PMID: 26938920] [PMID: 26938920]">Barrington 2016</a>; <a href="./references#CD007137-bbs2-0003" title="DaiJZ , XieC . The effect of lactoferrin supplementation combining Lactobacillus rhamnosus for prevention of late onset sepsis in premature neonates. China Practical Medicine2015;10:98-100. ">Dai 2015</a>; <a href="./references#CD007137-bbs2-0004" title="ISRCTN88261002. Enteral lactoferrin supplementation for very preterm infants: a randomised controlled trial. isrctn.com/ISRCTN88261002 (first received 5 June 2013). [DOI: 10.1186/ISRCTN88261002]">ELFIN 2018</a>; <a href="./references#CD007137-bbs2-0005" title="KaurG , GathwalaG . Efficacy of bovine lactoferrin supplementation in preventing late-onset sepsis in low birth weight neonates: a randomized placebo-controlled clinical trial. Journal of Tropical Pediatrics2015;61(5):370-6. [DOI: 10.1093/tropej/fmv044] [PMID: 26224129]">Kaur 2015</a>; <a href="./references#CD007137-bbs2-0006" title="Tarnow-MordiWO , Abdel-LatifME , MartinA , PammiM , RobledoK , ManzoniP , et al, LIFT collaborators. The Lactoferrin Infant Feeding Trial (LIFT): a pragmatic, randomised, multicentre study in very low birth weight infants. Lancet. Child and Adolescent Health.2020;4(6):444-54 (with online Supplementary Appendix pp S1-44). [DOI: 10.1016/S2352-4642(20)30093-6]">LIFT 2020</a>; <a href="./references#CD007137-bbs2-0007" title="LiuYH , GuanHS , LiangGJ , LiYZ , ZuoA . The effect of lactoferrin on low birth weight neonates during hospitalization. Maternal and Child Health Care of China2016;31(21):4464-5. ">Liu 2016</a>; <a href="./references#CD007137-bbs2-0008" title="ManzoniP , MeyerM , StolfiI , RinaldiM , CattaniS , PugniL , et al. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial. Early Human Development2014;90 Suppl 1:S60-5. [DOI: 10.1016/S0378-3782(14)70020-9] [PMID: 24709463]ManzoniP , RinaldiM , CattaniS , PugniL , RomeoMG , MessnerH , et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA2009;302(13):1421-8. [DOI: 10.1001/jama.2009.1403] [PMID: DOI: 10.1001/jama.2009.1403; PubMed: 19809023]]ManzoniP , StolfiI , MessnerH , CattaniS , LaforgiaN , RomeoMG , et al. Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial. Pediatrics2012;129(1):116-23. [PMID: 10.1542/peds.2011-0279; PubMed: 22184648]]">Manzoni 2014</a>; <a href="./references#CD007137-bbs2-0009" title="OchoaTJ , ZegarraJ , CamL , LlanosR , PezoA , CruzK , et al. Randomized controlled trial of lactoferrin for prevention of sepsis in Peruvian neonates less than 2500 g. Pediatric Infectious Disease Journal2015;34(6):571-6. [DOI: 10.1097/INF.0000000000000593] [PMID: 25973934]">Ochoa 2015</a>; <a href="./references#CD007137-bbs2-0010" title="OchoaT , ZegarraJ , BellomoS , CarcamoC , CamL , CastanedaA , et al, Neolacto Research Group. Randomized controlled trial of bovine lactoferrin for prevention of sepsis and neurodevelopmental impairment in infants weighing less than 2000 grams. Journal of Pediatrics (in press) 2020. ">Ochoa 2020</a>; <a href="./references#CD007137-bbs2-0011" title="ShermanMP , AdamkinDH , NiklasV , RadmacherP , ShermanJ , WertheimerF , et al. Randomized controlled trial of talactoferrin oral solution in preterm infants. Journal of Pediatrics2016;175:68-73. [DOI: 10.1016/j.jpeds.2016.04.084] [PMID: 27260839]">Sherman 2016</a>; <a href="./references#CD007137-bbs2-0012" title="TangJP , SunHQ , ZhengYH , LuGH . Randomized control trial of lactoferrin for the prevention of late onset sepsis in premature neonates. Maternal and Child Health Care of China2017;32(6):1223-5. ">Tang 2017</a>). </p> <section id="CD007137-sec-0053"> <h5 class="title">Late‐onset sepsis (outcome 1.1)</h5> <section id="CD007137-sec-0054"> <h6 class="title">All infants with either suspected or culture proven sepsis (outcome 1.1.1)</h6> <p>This outcome includes data on suspected (when reported) and confirmed late‐onset sepsis. Only 4 of 12 included studies (<a href="./references#CD007137-bbs2-0004" title="ISRCTN88261002. Enteral lactoferrin supplementation for very preterm infants: a randomised controlled trial. isrctn.com/ISRCTN88261002 (first received 5 June 2013). [DOI: 10.1186/ISRCTN88261002]">ELFIN 2018</a>; <a href="./references#CD007137-bbs2-0005" title="KaurG , GathwalaG . Efficacy of bovine lactoferrin supplementation in preventing late-onset sepsis in low birth weight neonates: a randomized placebo-controlled clinical trial. Journal of Tropical Pediatrics2015;61(5):370-6. [DOI: 10.1093/tropej/fmv044] [PMID: 26224129]">Kaur 2015</a>; <a href="./references#CD007137-bbs2-0009" title="OchoaTJ , ZegarraJ , CamL , LlanosR , PezoA , CruzK , et al. Randomized controlled trial of lactoferrin for prevention of sepsis in Peruvian neonates less than 2500 g. Pediatric Infectious Disease Journal2015;34(6):571-6. [DOI: 10.1097/INF.0000000000000593] [PMID: 25973934]">Ochoa 2015</a>; <a href="./references#CD007137-bbs2-0010" title="OchoaT , ZegarraJ , BellomoS , CarcamoC , CamL , CastanedaA , et al, Neolacto Research Group. Randomized controlled trial of bovine lactoferrin for prevention of sepsis and neurodevelopmental impairment in infants weighing less than 2000 grams. Journal of Pediatrics (in press) 2020. ">Ochoa 2020</a>) reported data on suspected sepsis and the rest reported culture‐proven sepsis. Lactoferrin supplementation of enteral feeds in preterm infants decreased suspected or culture proven late‐onset sepsis (typical RR 0.80, 95% CI 0.72 to 0.89; typical RD ‐0.05, 95% CI, ‐0.07 to ‐0.02; NNTB 20, 95% CI 14 to 50; 12 studies, 5425 participants) (<a href="./references#CD007137-fig-0009" title="">Analysis 1.1</a>)(<a href="#CD007137-fig-0006">Figure 6</a>). Results showed moderate heterogeneity (I<sup>2</sup> = 59%) among the twelve trials for this outcome. We downgraded evidence to low certainty because of risk of bias in the included trials, and asymmetry of the funnel plot. </p> <div class="figure" id="CD007137-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Lactoferrin supplementation with enteral feeds versus placebo, outcome: 1.1 Any late‐onset sepsis." data-id="CD007137-fig-0006" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-FIG-06.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Lactoferrin supplementation with enteral feeds versus placebo, outcome: 1.1 Any late‐onset sepsis. </p> </div> </div> </div> <p>Sensitivity analysis of good methodological studies (excluding studies of poor methodology: <a href="./references#CD007137-bbs2-0003" title="DaiJZ , XieC . The effect of lactoferrin supplementation combining Lactobacillus rhamnosus for prevention of late onset sepsis in premature neonates. China Practical Medicine2015;10:98-100. ">Dai 2015</a>; <a href="./references#CD007137-bbs2-0007" title="LiuYH , GuanHS , LiangGJ , LiYZ , ZuoA . The effect of lactoferrin on low birth weight neonates during hospitalization. Maternal and Child Health Care of China2016;31(21):4464-5. ">Liu 2016</a>; <a href="./references#CD007137-bbs2-0012" title="TangJP , SunHQ , ZhengYH , LuGH . Randomized control trial of lactoferrin for the prevention of late onset sepsis in premature neonates. Maternal and Child Health Care of China2017;32(6):1223-5. ">Tang 2017</a>) showed that lactoferrin supplementation of enteral feeds in preterm infants decreased suspected or culture proven late‐onset sepsis (typical RR 0.82, 95% CI, 0.74 to 0.91; typical RD ‐0.04, 95% CI, ‐0.06 to ‐0.02; NNTB 20, 95% CI 14 to 50; 9 studies, 4702 participants, (low‐certainty evidence). Results showed moderate heterogeneity (I<sup>2</sup> = 61%) among the nine trials for this outcome. (<a href="./references#CD007137-fig-0019" title="">Analysis 1.11</a>) </p> <section id="CD007137-sec-0055"> <p><b>Subgroup analyses for the outcome of late‐onset sepsis</b></p> <p><b>Culture proven sepsis (outcome 1.1.2)</b> </p> <p>All 12 included studies reported on culture proven sepsis.The estimated risk ratio for the outcome of culture proven sepsis was (typical RR 0.83, 95% CI 0.73 to 0.94; typical RD ‐0.03, 95% CI, ‐0.040 to ‐0.01; NNTB 33, 95% CI 25 to 100; 12 studies, 5425 participants, low‐certainty evidence). Results showed moderate heterogeneity (I<sup>2</sup> = 54%) among the twelve trials for this outcome. (<a href="./references#CD007137-fig-0009" title="">Analysis 1.1</a>) </p> </section> </section> <section id="CD007137-sec-0056"> <h6 class="title">Birth weight &lt; 1000 g (outcome 1.1.3)</h6> <p>The estimated risk ratio for the outcome of late‐onset sepsis in ELBW infants was 0.31 (95% CI 0.14 to 0.70; RD ‐0.25, 95% CI ‐0.40 to ‐0.10; NNTB 4, 95% CI 2.5 to 25; 1 study, 113 participants) (<a href="#CD007137-fig-0006">Figure 6</a>). </p> </section> <section id="CD007137-sec-0057"> <h6 class="title">Birth weight 1000 to 1500 g (outcome 1.1.4)</h6> <p>The estimated risk ratio for the outcome of late‐onset sepsis in this subgroup was 0.46 (95% CI 0.12 to 1.74; RD ‐0.03, 95% CI ‐0.09 to 0.020; 1 study, 208 participants) (<a href="#CD007137-fig-0006">Figure 6</a>). </p> </section> <section id="CD007137-sec-0058"> <h6 class="title">Exclusively maternal milk‐fed infants (outcome 1.1.5)</h6> <p>The estimated risk ratio for the outcome of late‐onset sepsis in exclusively maternal milk fed infants was 1.02 (95% CI 0.81 to 1.30; RD 0.01, 95% CI ‐0.06 to 0.07; 2 studies, 685 participants) (<a href="#CD007137-fig-0006">Figure 6</a>). This suggests no differences in late‐onset sepsis among preterm infants exclusively receiving maternal milk supplemented with lactoferrin. </p> </section> <section id="CD007137-sec-0059"> <h6 class="title">Formula‐fed infants (outcome 1.1.6)</h6> <p>The estimated risk ratio for the outcome of late‐onset sepsis in formula‐fed infants was 0.75 (95% CI 0.38 to 1.50; RD ‐0.05, 95% CI ‐0.16 to 0.07; 2 studies, 159 participants) (<a href="#CD007137-fig-0006">Figure 6</a>). </p> </section> </section> <section id="CD007137-sec-0060"> <h5 class="title">NEC ≥ stage II (outcome 1.2)</h5> <p>Enteral lactoferrin supplementation in preterm infants had no effect on NEC ≥ stage II (typical RR 1.10, 95% CI, 0.86 to 1.41; typical RD ‐0.00, 95% CI, ‐0.02 to 0.01; 7 studies, 4874 participants) (<a href="#CD007137-fig-0007">Figure 7</a>). We observed mild heterogeneity (I<sup>2</sup> = 37%) among the seven trials for this outcome. We downgraded the certainty of evidence to low because of risk of bias in the included trials and imprecision. </p> <div class="figure" id="CD007137-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Lactoferrin supplementation with enteral feeds versus placebo, outcome: 1.2 NEC ≥ stage II." data-id="CD007137-fig-0007" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-FIG-07.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Lactoferrin supplementation with enteral feeds versus placebo, outcome: 1.2 NEC ≥ stage II. </p> </div> </div> </div> </section> <section id="CD007137-sec-0061"> <h5 class="title">All‐cause mortality (outcome 1.3)</h5> <p>Lactoferrin supplementation of enteral feeds in preterm infants did not affect 'all‐cause mortality' (typical RR 0.90, 95% CI 0.69 to 1.17; typical RD ‐0.00, 95% CI, ‐0.01 to 0.01; 11 studies, 5510 participants) (<a href="#CD007137-fig-0008">Figure 8</a>). We noted mild heterogeneity (I<sup>2</sup> = 26%) among the 11 included trials for this outcome. We downgraded the certainty of evidence to very low because of risk of bias in the included studies, imprecision and asymmetry of the funnel plot (publication bias and small poor‐certainty studies). </p> <div class="figure" id="CD007137-fig-0008"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 8</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Lactoferrin supplementation with enteral feeds versus placebo, outcome: 1.3 All‐cause mortality." data-id="CD007137-fig-0008" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-FIG-08.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Lactoferrin supplementation with enteral feeds versus placebo, outcome: 1.3 All‐cause mortality. </p> </div> </div> </div> </section> <section id="CD007137-sec-0062"> <h5 class="title">Bacterial sepsis (outcome 1.4)</h5> <p>The estimated risk ratio for the outcome of bacterial sepsis in preterm infants was 0.86 (95% CI, 0.74 to 1.00; RD ‐0.02, 95% CI, ‐0.05 to 0.00; 8 studies, 3575 participants). We downgraded the certainty of evidence to moderate because of unclear risk of detection bias in the included trials and unclear risk of selection bias in one trial. </p> </section> <section id="CD007137-sec-0063"> <h5 class="title">Fungal sepsis (outcome 1.5)</h5> <p>The estimated risk ratio for the outcome of fungal sepsis in preterm infants was 0.23 (95% CI, 0.10 to 0.54; RD ‐0.01, 95% CI, ‐0.02 to ‐0.01; NNTB 100, 95% CI 50 to 100; 6 studies, 3266 participants). This suggests a decrease in fungal sepsis among preterm infants whose feedings were supplemented with lactoferrin. We downgraded the certainty of evidence to moderate because of risk of bias. </p> </section> <section id="CD007137-sec-0064"> <h5 class="title">Chronic lung disease (outcome 1.6)</h5> <p>The estimated typical risk ratio for the outcome of chronic lung disease was 1.00 (95% CI 0.89 to 1.12 and typical RD was 0.00, 95% CI ‐0.03 to 0.03; 5 studies, 2984 participants) (Figure 10). We observed no heterogeneity (I<sup>2</sup> = 0%) among the four trials for this outcome. We downgraded the certainty of evidence to moderate because of unclear risk of bias in the included studies. </p> </section> <section id="CD007137-sec-0065"> <h5 class="title">Duration of mechanical ventilation (outcome 1.7)</h5> <p>The estimated mean difference for the outcome of duration of mechanical ventilation in preterm infants was ‐0.45 (95% CI, ‐1.30 to 0.39; 3 studies, 925 participants). We downgraded the certainty of evidence to low because of unclear risk of bias, and because data were derived from only two studies (imprecision). </p> </section> <section id="CD007137-sec-0066"> <h5 class="title">Length of hospital stay among survivors (outcome 1.8)</h5> <p>The estimated mean difference for the outcome of length of hospital stay among survivors in preterm infants was ‐2.38 (95% CI, ‐4.67 to ‐0.09; 3 studies, 1079 participants). We downgraded the certainty of evidence to low because of unclear risk of bias and severe heterogeneity (I<sup>2</sup> = 85%). </p> </section> <section id="CD007137-sec-0067"> <h5 class="title">Threshold retinopathy of prematurity (outcome 1.9)</h5> <p>The estimated risk ratio for the outcome of threshold ROP in preterm infants was 0.88 (95% CI, 0.69 to 1.13; RD ‐0.01, 95% CI, ‐0.02 to 0.01; 5 studies, 4515 participants). We downgraded the certainty of evidence to low because of unclear risk of bias, and moderate heterogeneity (I<sup>2</sup> = 46%). </p> </section> <section id="CD007137-sec-0068"> <h5 class="title">Urinary tract infection (outcome 1.10)</h5> <p>The estimated risk ratio for the outcome of urinary tract infection in preterm infants was 0.33 (95% CI, 0.13 to 0.86; RD ‐0.03, 95% CI, ‐0.05 to ‐0.01; NNTB 33, 95% CI 20 to 100; 3 studies, 854 participants). We downgraded the certainty of evidence to low because of unclear risk of bias, and because data were derived from only two studies (imprecision). </p> </section> <section id="CD007137-sec-0069"> <h5 class="title">Neurodevelopmental outcome assessment at 24 months of age by Mullen testing (outcome 1.12) </h5> <p>There were no differences in the estimated mean difference for neurodevelopmental assessment at the age of 24 months by Mullen test after enteral lactoferrin supplementation. The estimated mean differences for subcomponents of the Mullen testing were: composite MD 0.70 (95% CI ‐2.36 to 3.76), gross motor ‐1.00 (95% CI ‐2.71 to 0.71), visual reception 0.60 (95% CI ‐1.53 to 2.73), fine motor ‐0.60 (95% CI ‐2.92 to 1.72), receptive language 0.30 (95% CI ‐2.42 to 3.02) and expressive language 0.90 (95% CI ‐0.83 to 2.63)(1 study, 292 participants). We downgraded the certainty of evidence to low because of unclear risk of bias, and because data were derived from only one study (<a href="./references#CD007137-bbs2-0010" title="OchoaT , ZegarraJ , BellomoS , CarcamoC , CamL , CastanedaA , et al, Neolacto Research Group. Randomized controlled trial of bovine lactoferrin for prevention of sepsis and neurodevelopmental impairment in infants weighing less than 2000 grams. Journal of Pediatrics (in press) 2020. ">Ochoa 2020</a>)(imprecision). </p> </section> <section id="CD007137-sec-0070"> <h5 class="title">Neurodevelopmental outcome assessment at 24 months of age by Bayley III testing (outcome 1.13) </h5> <p>There were no differences in the estimated mean difference for neurodevelopmental assessment at the age of 24 months by Bayley III testing after enteral lactoferrin supplementation. The estimated mean differences for subcomponents of the Bayley III testing were: cognitive MD ‐0.70 (95% CI ‐2.70 to 1.30), language 1.20 (95% CI ‐1.24 to 3.64), motor ‐0.90 (95% CI ‐3.73 to 1.93) and social emotional score ‐1.00 (95% CI ‐5.98 to 3.98)(1 study, 292 participants). We downgraded the certainty of evidence to low because of unclear risk of bias, and because data were derived from only one study (<a href="./references#CD007137-bbs2-0010" title="OchoaT , ZegarraJ , BellomoS , CarcamoC , CamL , CastanedaA , et al, Neolacto Research Group. Randomized controlled trial of bovine lactoferrin for prevention of sepsis and neurodevelopmental impairment in infants weighing less than 2000 grams. Journal of Pediatrics (in press) 2020. ">Ochoa 2020</a>) (imprecision). </p> </section> <section id="CD007137-sec-0071"> <h5 class="title">Other outcomes</h5> <p>No study reported adverse effects for this comparison.</p> </section> </section> <section id="CD007137-sec-0072"> <h4 class="title">Lactoferrin supplementation of enteral feeds in combination with probiotics versus placebo (comparison 2) </h4> <p>We derived outcome data for analyses for this comparison from three trials (<a href="./references#CD007137-bbs2-0003" title="DaiJZ , XieC . The effect of lactoferrin supplementation combining Lactobacillus rhamnosus for prevention of late onset sepsis in premature neonates. China Practical Medicine2015;10:98-100. ">Dai 2015</a>; <a href="./references#CD007137-bbs2-0008" title="ManzoniP , MeyerM , StolfiI , RinaldiM , CattaniS , PugniL , et al. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial. Early Human Development2014;90 Suppl 1:S60-5. [DOI: 10.1016/S0378-3782(14)70020-9] [PMID: 24709463]ManzoniP , RinaldiM , CattaniS , PugniL , RomeoMG , MessnerH , et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA2009;302(13):1421-8. [DOI: 10.1001/jama.2009.1403] [PMID: DOI: 10.1001/jama.2009.1403; PubMed: 19809023]]ManzoniP , StolfiI , MessnerH , CattaniS , LaforgiaN , RomeoMG , et al. Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial. Pediatrics2012;129(1):116-23. [PMID: 10.1542/peds.2011-0279; PubMed: 22184648]]">Manzoni 2014</a>; <a href="./references#CD007137-bbs2-0012" title="TangJP , SunHQ , ZhengYH , LuGH . Randomized control trial of lactoferrin for the prevention of late onset sepsis in premature neonates. Maternal and Child Health Care of China2017;32(6):1223-5. ">Tang 2017</a>), in which investigators randomly assigned preterm infants to enteral bovine lactoferrin or enteral bovine lactoferrin in combination with the probiotic <i>Lactobacillus rhamnosus</i> GG or placebo. All three studies included in this comparison used the same probiotic organism at the same dosage (6 x 10<sup>9</sup> colony forming units/day) but for different duration. We conducted subgroup analyses using birth weight and types of milk subgroups for late‐onset sepsis for the outcome of 'late‐onset sepsis.' Data for subgroup analyses for other outcomes were not available. </p> <section id="CD007137-sec-0073"> <h5 class="title">Late‐onset sepsis (outcome 2.1)</h5> <section id="CD007137-sec-0074"> <h6 class="title">All infants with both suspected and confirmed sepsis (outcome 2.1.1)</h6> <p>The studies eligible for inclusion for this outcome reported only confirmed sepsis (<a href="./references#CD007137-bbs2-0003" title="DaiJZ , XieC . The effect of lactoferrin supplementation combining Lactobacillus rhamnosus for prevention of late onset sepsis in premature neonates. China Practical Medicine2015;10:98-100. ">Dai 2015</a>; <a href="./references#CD007137-bbs2-0008" title="ManzoniP , MeyerM , StolfiI , RinaldiM , CattaniS , PugniL , et al. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial. Early Human Development2014;90 Suppl 1:S60-5. [DOI: 10.1016/S0378-3782(14)70020-9] [PMID: 24709463]ManzoniP , RinaldiM , CattaniS , PugniL , RomeoMG , MessnerH , et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA2009;302(13):1421-8. [DOI: 10.1001/jama.2009.1403] [PMID: DOI: 10.1001/jama.2009.1403; PubMed: 19809023]]ManzoniP , StolfiI , MessnerH , CattaniS , LaforgiaN , RomeoMG , et al. Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial. Pediatrics2012;129(1):116-23. [PMID: 10.1542/peds.2011-0279; PubMed: 22184648]]">Manzoni 2014</a>; <a href="./references#CD007137-bbs2-0012" title="TangJP , SunHQ , ZhengYH , LuGH . Randomized control trial of lactoferrin for the prevention of late onset sepsis in premature neonates. Maternal and Child Health Care of China2017;32(6):1223-5. ">Tang 2017</a>). Lactoferrin supplementation of enteral feeds in combination with probiotics in preterm infants decreased confirmed late‐onset sepsis (typical RR 0.25, 95% CI 0.14 to 0.46; typical RD ‐0.13, 95% CI ‐0.18 to ‐0.08; NNTB 8, 95% CI 6 to 13; 3 studies, 564 participants). Results showed no heterogeneity (I<sup>2</sup> = 0%) among the three trials for this outcome. We downgraded the certainty of evidence to low because of risk of bias in the included studies and the data from only three studies. There were no data for suspected sepsis from the included 3 studies. </p> </section> <section id="CD007137-sec-0075"> <h6 class="title">Birth weight &lt; 1000 g (outcome 2.1.2)</h6> <p>The estimated risk ratio for the outcome of late‐onset sepsis in ELBW infants was 0.30 (95% CI 0.13 to 0.69; RD ‐0.26, 95% CI ‐0.40 to ‐0.11; NNTB 5, 95% CI 2 to 9; 1 study, 114 participants). This suggests a decrease in late‐onset sepsis among ELBW infants who were supplemented with lactoferrin in combination with probiotics. We downgraded the certainty of evidence to low because data were obtained from only one study (<a href="./references#CD007137-bbs2-0008" title="ManzoniP , MeyerM , StolfiI , RinaldiM , CattaniS , PugniL , et al. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial. Early Human Development2014;90 Suppl 1:S60-5. [DOI: 10.1016/S0378-3782(14)70020-9] [PMID: 24709463]ManzoniP , RinaldiM , CattaniS , PugniL , RomeoMG , MessnerH , et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA2009;302(13):1421-8. [DOI: 10.1001/jama.2009.1403] [PMID: DOI: 10.1001/jama.2009.1403; PubMed: 19809023]]ManzoniP , StolfiI , MessnerH , CattaniS , LaforgiaN , RomeoMG , et al. Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial. Pediatrics2012;129(1):116-23. [PMID: 10.1542/peds.2011-0279; PubMed: 22184648]]">Manzoni 2014</a>) (imprecision) and risk of bias. </p> </section> <section id="CD007137-sec-0076"> <h6 class="title">Birth weight 1000 to 1500 g (outcome 2.1.3)</h6> <p>The estimated risk ratio for the outcome of late‐onset sepsis in preterm infants with birth weight from 1000 to 1500 g was 0.16 (95% CI 0.02 to 1.27; RD ‐0.05, 95% CI ‐0.11 to 0.0; 1 study, 205 participants). We downgraded the certainty of evidence to low because data were obtained from only one study (<a href="./references#CD007137-bbs2-0008" title="ManzoniP , MeyerM , StolfiI , RinaldiM , CattaniS , PugniL , et al. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial. Early Human Development2014;90 Suppl 1:S60-5. [DOI: 10.1016/S0378-3782(14)70020-9] [PMID: 24709463]ManzoniP , RinaldiM , CattaniS , PugniL , RomeoMG , MessnerH , et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA2009;302(13):1421-8. [DOI: 10.1001/jama.2009.1403] [PMID: DOI: 10.1001/jama.2009.1403; PubMed: 19809023]]ManzoniP , StolfiI , MessnerH , CattaniS , LaforgiaN , RomeoMG , et al. Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial. Pediatrics2012;129(1):116-23. [PMID: 10.1542/peds.2011-0279; PubMed: 22184648]]">Manzoni 2014</a>)(imprecision) and risk of bias. </p> </section> <section id="CD007137-sec-0077"> <h6 class="title">Exclusively maternal milk‐fed infants (outcome 2.1.4)</h6> <p>The estimated risk ratio for the outcome of late‐onset sepsis in preterm infants fed exclusively on maternal milk was 0.33 (95% CI 0.07 to 1.48; RD ‐0.13, 95% CI ‐0.28 to 0.02; 1 study, 69 participants). We downgraded the certainty of evidence to low because data were obtained from only one study (<a href="./references#CD007137-bbs2-0008" title="ManzoniP , MeyerM , StolfiI , RinaldiM , CattaniS , PugniL , et al. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial. Early Human Development2014;90 Suppl 1:S60-5. [DOI: 10.1016/S0378-3782(14)70020-9] [PMID: 24709463]ManzoniP , RinaldiM , CattaniS , PugniL , RomeoMG , MessnerH , et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA2009;302(13):1421-8. [DOI: 10.1001/jama.2009.1403] [PMID: DOI: 10.1001/jama.2009.1403; PubMed: 19809023]]ManzoniP , StolfiI , MessnerH , CattaniS , LaforgiaN , RomeoMG , et al. Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial. Pediatrics2012;129(1):116-23. [PMID: 10.1542/peds.2011-0279; PubMed: 22184648]]">Manzoni 2014</a>) (imprecision) and risk of bias. </p> </section> <section id="CD007137-sec-0078"> <h6 class="title">Exclusively formula‐fed infants (outcome 2.1.5)</h6> <p>The estimated risk ratio for the outcome of late‐onset sepsis in preterm infants fed formula milk was 0.09 (95% CI 0.01 to 1.67; RD ‐0.18, 95% CI ‐0.35 to ‐0.01; 1 study, 48 participants). We downgraded the certainty of evidence to low because data were obtained from only one study (<a href="./references#CD007137-bbs2-0008" title="ManzoniP , MeyerM , StolfiI , RinaldiM , CattaniS , PugniL , et al. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial. Early Human Development2014;90 Suppl 1:S60-5. [DOI: 10.1016/S0378-3782(14)70020-9] [PMID: 24709463]ManzoniP , RinaldiM , CattaniS , PugniL , RomeoMG , MessnerH , et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA2009;302(13):1421-8. [DOI: 10.1001/jama.2009.1403] [PMID: DOI: 10.1001/jama.2009.1403; PubMed: 19809023]]ManzoniP , StolfiI , MessnerH , CattaniS , LaforgiaN , RomeoMG , et al. Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial. Pediatrics2012;129(1):116-23. [PMID: 10.1542/peds.2011-0279; PubMed: 22184648]]">Manzoni 2014</a>) (imprecision) and risk of bias. </p> </section> </section> <section id="CD007137-sec-0079"> <h5 class="title">NEC ≥ stage II (outcome 2.2)</h5> <p>Lactoferrin supplementation of enteral feeds in combination with probiotics in preterm infants decreased NEC ≥ stage II in preterm infants (RR 0.04, 95% CI 0.00 to 0.62; RD ‐0.05, 95% CI ‐0.08 to ‐0.03; NNTB 20, 95% CI 12.5 to 33.3; 1 study, 496 participants). We downgraded the certainty of evidence to very low because data were obtained from only one study (<a href="./references#CD007137-bbs2-0008" title="ManzoniP , MeyerM , StolfiI , RinaldiM , CattaniS , PugniL , et al. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial. Early Human Development2014;90 Suppl 1:S60-5. [DOI: 10.1016/S0378-3782(14)70020-9] [PMID: 24709463]ManzoniP , RinaldiM , CattaniS , PugniL , RomeoMG , MessnerH , et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA2009;302(13):1421-8. [DOI: 10.1001/jama.2009.1403] [PMID: DOI: 10.1001/jama.2009.1403; PubMed: 19809023]]ManzoniP , StolfiI , MessnerH , CattaniS , LaforgiaN , RomeoMG , et al. Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial. Pediatrics2012;129(1):116-23. [PMID: 10.1542/peds.2011-0279; PubMed: 22184648]]">Manzoni 2014</a>) (serious imprecision) and risk of bias. </p> </section> <section id="CD007137-sec-0080"> <h5 class="title">All‐cause mortality (outcome 2.3)</h5> <p>The estimated risk ratio for the outcome of 'all‐cause mortality' in preterm infants was 0.58, 95% CI 0.30 to 1.13; RD ‐0.03, 95% CI ‐0.06 to 0.01; two studies, 671 participants). We downgraded the certainty of evidence to very low because data were obtained from only two studies (<a href="./references#CD007137-bbs2-0008" title="ManzoniP , MeyerM , StolfiI , RinaldiM , CattaniS , PugniL , et al. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial. Early Human Development2014;90 Suppl 1:S60-5. [DOI: 10.1016/S0378-3782(14)70020-9] [PMID: 24709463]ManzoniP , RinaldiM , CattaniS , PugniL , RomeoMG , MessnerH , et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA2009;302(13):1421-8. [DOI: 10.1001/jama.2009.1403] [PMID: DOI: 10.1001/jama.2009.1403; PubMed: 19809023]]ManzoniP , StolfiI , MessnerH , CattaniS , LaforgiaN , RomeoMG , et al. Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial. Pediatrics2012;129(1):116-23. [PMID: 10.1542/peds.2011-0279; PubMed: 22184648]]">Manzoni 2014</a>; <a href="./references#CD007137-bbs2-0012" title="TangJP , SunHQ , ZhengYH , LuGH . Randomized control trial of lactoferrin for the prevention of late onset sepsis in premature neonates. Maternal and Child Health Care of China2017;32(6):1223-5. ">Tang 2017</a>) (serious imprecision) and risk of bias. </p> </section> <section id="CD007137-sec-0081"> <h5 class="title">Bacterial sepsis (outcome 2.4)</h5> <p>The estimated risk ratio for the outcome of bacterial sepsis in preterm infants was 0.28 (95% CI 0.11 to 0.72; RD ‐0.09, 95% CI ‐0.14 to ‐0.03; NNTB 11, 95% CI 7 to 33; 1 study, 319 participants). We downgraded the certainty of evidence to low because data were obtained from only one study (<a href="./references#CD007137-bbs2-0008" title="ManzoniP , MeyerM , StolfiI , RinaldiM , CattaniS , PugniL , et al. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial. Early Human Development2014;90 Suppl 1:S60-5. [DOI: 10.1016/S0378-3782(14)70020-9] [PMID: 24709463]ManzoniP , RinaldiM , CattaniS , PugniL , RomeoMG , MessnerH , et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA2009;302(13):1421-8. [DOI: 10.1001/jama.2009.1403] [PMID: DOI: 10.1001/jama.2009.1403; PubMed: 19809023]]ManzoniP , StolfiI , MessnerH , CattaniS , LaforgiaN , RomeoMG , et al. Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial. Pediatrics2012;129(1):116-23. [PMID: 10.1542/peds.2011-0279; PubMed: 22184648]]">Manzoni 2014</a>) and unclear risk of bias. </p> </section> <section id="CD007137-sec-0082"> <h5 class="title">Fungal sepsis (outcome 2.5)</h5> <p>The estimated risk ratio for the outcome of fungal sepsis in preterm infants was 0.24 (95% CI 0.08 to 0.71; RD ‐0.05, 95% CI ‐0.09 to ‐0.02; NNTB 20, 95% CI 11 to 50; 2 studies, 494 participants). This suggests a decrease in fungal sepsis among preterm infants whose feedings were supplemented with lactoferrin in combination with probiotics. We downgraded the certainty of evidence to low because of unclear risk of bias, and because data were obtained from only two studies (<a href="./references#CD007137-bbs2-0008" title="ManzoniP , MeyerM , StolfiI , RinaldiM , CattaniS , PugniL , et al. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial. Early Human Development2014;90 Suppl 1:S60-5. [DOI: 10.1016/S0378-3782(14)70020-9] [PMID: 24709463]ManzoniP , RinaldiM , CattaniS , PugniL , RomeoMG , MessnerH , et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA2009;302(13):1421-8. [DOI: 10.1001/jama.2009.1403] [PMID: DOI: 10.1001/jama.2009.1403; PubMed: 19809023]]ManzoniP , StolfiI , MessnerH , CattaniS , LaforgiaN , RomeoMG , et al. Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial. Pediatrics2012;129(1):116-23. [PMID: 10.1542/peds.2011-0279; PubMed: 22184648]]">Manzoni 2014</a>, <a href="./references#CD007137-bbs2-0012" title="TangJP , SunHQ , ZhengYH , LuGH . Randomized control trial of lactoferrin for the prevention of late onset sepsis in premature neonates. Maternal and Child Health Care of China2017;32(6):1223-5. ">Tang 2017</a>) (imprecision). </p> </section> <section id="CD007137-sec-0083"> <h5 class="title">Chronic lung disease (outcome 2.6)</h5> <p>The study definition of chronic lung disease was oxygen requirement greater than 30% for 28 days, positive‐pressure ventilation at 36 weeks, or both. We have requested data from the study authors on infants who required oxygen at 36 weeks' corrected age. </p> <p>The estimated risk ratio for the outcome of chronic lung disease in preterm infants was 0.67 (95% CI 0.25 to 1.79; RD ‐0.02, 95% CI ‐0.07 to 0.03; 1 study, 319 participants). We downgraded the certainty of evidence to very low because data were obtained from only one study (<a href="./references#CD007137-bbs2-0008" title="ManzoniP , MeyerM , StolfiI , RinaldiM , CattaniS , PugniL , et al. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial. Early Human Development2014;90 Suppl 1:S60-5. [DOI: 10.1016/S0378-3782(14)70020-9] [PMID: 24709463]ManzoniP , RinaldiM , CattaniS , PugniL , RomeoMG , MessnerH , et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA2009;302(13):1421-8. [DOI: 10.1001/jama.2009.1403] [PMID: DOI: 10.1001/jama.2009.1403; PubMed: 19809023]]ManzoniP , StolfiI , MessnerH , CattaniS , LaforgiaN , RomeoMG , et al. Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial. Pediatrics2012;129(1):116-23. [PMID: 10.1542/peds.2011-0279; PubMed: 22184648]]">Manzoni 2014</a>) (serious imprecision) and unclear risk of bias. </p> </section> <section id="CD007137-sec-0084"> <h5 class="title">Duration of mechanical ventilation (outcome 2.7)</h5> <p>The estimated mean difference for the outcome of 'duration of mechanical ventilation' in preterm infants was ‐1.10 (95% CI ‐3.04 to 0.84; 1 study, 321 participants). We downgraded the certainty of evidence to very low because data were obtained from only one study (<a href="./references#CD007137-bbs2-0008" title="ManzoniP , MeyerM , StolfiI , RinaldiM , CattaniS , PugniL , et al. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial. Early Human Development2014;90 Suppl 1:S60-5. [DOI: 10.1016/S0378-3782(14)70020-9] [PMID: 24709463]ManzoniP , RinaldiM , CattaniS , PugniL , RomeoMG , MessnerH , et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA2009;302(13):1421-8. [DOI: 10.1001/jama.2009.1403] [PMID: DOI: 10.1001/jama.2009.1403; PubMed: 19809023]]ManzoniP , StolfiI , MessnerH , CattaniS , LaforgiaN , RomeoMG , et al. Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial. Pediatrics2012;129(1):116-23. [PMID: 10.1542/peds.2011-0279; PubMed: 22184648]]">Manzoni 2014</a>) (serious imprecision) and unclear risk of bias. </p> </section> <section id="CD007137-sec-0085"> <h5 class="title">Length of hospital stay among survivors (outcome 2.8)</h5> <p>The estimated mean difference for the outcome of 'length of hospital stay among survivors' in preterm infants was 2.00 (95% CI ‐1.88 to 5.88; 1 study, 496 participants). We downgraded the certainty of evidence to very low because data were obtained from only one study (<a href="./references#CD007137-bbs2-0008" title="ManzoniP , MeyerM , StolfiI , RinaldiM , CattaniS , PugniL , et al. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial. Early Human Development2014;90 Suppl 1:S60-5. [DOI: 10.1016/S0378-3782(14)70020-9] [PMID: 24709463]ManzoniP , RinaldiM , CattaniS , PugniL , RomeoMG , MessnerH , et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA2009;302(13):1421-8. [DOI: 10.1001/jama.2009.1403] [PMID: DOI: 10.1001/jama.2009.1403; PubMed: 19809023]]ManzoniP , StolfiI , MessnerH , CattaniS , LaforgiaN , RomeoMG , et al. Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial. Pediatrics2012;129(1):116-23. [PMID: 10.1542/peds.2011-0279; PubMed: 22184648]]">Manzoni 2014</a>) (serious imprecision) and unclear risk of bias. </p> </section> <section id="CD007137-sec-0086"> <h5 class="title">Threshold retinopathy of prematurity (outcome 2.9)</h5> <p>The estimated risk ratio for the outcome of threshold ROP in preterm infants was 0.76 (95% CI 0.39 to 1.49; RD ‐0.03, 95% CI ‐0.09 to 0.04; 1 study, 319 participants). We downgraded the certainty of evidence to very low because data were obtained from only one study (<a href="./references#CD007137-bbs2-0008" title="ManzoniP , MeyerM , StolfiI , RinaldiM , CattaniS , PugniL , et al. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial. Early Human Development2014;90 Suppl 1:S60-5. [DOI: 10.1016/S0378-3782(14)70020-9] [PMID: 24709463]ManzoniP , RinaldiM , CattaniS , PugniL , RomeoMG , MessnerH , et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA2009;302(13):1421-8. [DOI: 10.1001/jama.2009.1403] [PMID: DOI: 10.1001/jama.2009.1403; PubMed: 19809023]]ManzoniP , StolfiI , MessnerH , CattaniS , LaforgiaN , RomeoMG , et al. Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial. Pediatrics2012;129(1):116-23. [PMID: 10.1542/peds.2011-0279; PubMed: 22184648]]">Manzoni 2014</a>) (serious imprecision) and unclear risk of bias. </p> </section> <section id="CD007137-sec-0087"> <h5 class="title">Urinary tract infection (outcome 2.10)</h5> <p>The estimated risk ratio for the outcome of urinary tract infection in preterm infants was 0.67 (95% CI 0.25 to 1.79; RD ‐0.02, 95% CI ‐0.07 to 0.03; 1 study, 319 participants). We downgraded the certainty of evidence to very low because data were obtained from only one study (<a href="./references#CD007137-bbs2-0008" title="ManzoniP , MeyerM , StolfiI , RinaldiM , CattaniS , PugniL , et al. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial. Early Human Development2014;90 Suppl 1:S60-5. [DOI: 10.1016/S0378-3782(14)70020-9] [PMID: 24709463]ManzoniP , RinaldiM , CattaniS , PugniL , RomeoMG , MessnerH , et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA2009;302(13):1421-8. [DOI: 10.1001/jama.2009.1403] [PMID: DOI: 10.1001/jama.2009.1403; PubMed: 19809023]]ManzoniP , StolfiI , MessnerH , CattaniS , LaforgiaN , RomeoMG , et al. Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial. Pediatrics2012;129(1):116-23. [PMID: 10.1542/peds.2011-0279; PubMed: 22184648]]">Manzoni 2014</a>) (serious imprecision) and unclear risk of bias. </p> </section> <section id="CD007137-sec-0088"> <h5 class="title">Other outcomes</h5> <p>The studies included in this comparison reported no adverse effects due to lactoferrin supplementation of enteral feeds in combination with probiotics. Included studies did not assess neurological outcome at two years of age or older or PVL. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD007137-sec-0089" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD007137-sec-0089"></div> <section id="CD007137-sec-0090"> <h3 class="title" id="CD007137-sec-0090">Summary of main results</h3> <p>We identified 12 randomized controlled trials that enrolled 5425 preterm infants and evaluated lactoferrin supplementation of enteral feeds with or without probiotics (<i>Lactobacillus rhamnosus</i> GG) compared with placebo. </p> <p><b>I. Lactoferrin supplementation of enteral feeds without probiotics compared with placebo</b> </p> <p> <ul id="CD007137-list-0011"> <li> <p>Decreased <b>late‐onset sepsis (both suspected and confirmed sepsis)</b> (typical RR 0.80, 95% CI 0.72 to 0.89; typical RD ‐0.05, 95% CI, ‐0.07 to ‐0.02; NNTB 20, 95% CI 14 to 50; 12 studies, 5425 participants, low‐certainty evidence) </p> </li> <li> <p>Subgroup analysis of data on <b>confirmed late‐onset sepsis</b> suggests decrease in late‐onset sepsis with enteral lactoferrin supplementation (typical RR 0.83, 95% CI 0.73 to 0.94; typical RD ‐0.03, 95% CI, ‐0.04 to ‐0.01; NNTB 33, 95% CI 25 to 100; 12 studies, 5425 participants, low‐certainty evidence) </p> </li> <li> <p>Sensitivity analysis including only good methodological certainty studies suggested a decrease in late‐onset sepsis (<b>both suspected and confirmed</b>) with enteral lactoferrin supplementation (typical RR 0.82, 95% CI, 0.74 to 0.91; typical RD ‐0.04, 95% CI, ‐0.06 to ‐0.02; NNTB 20, 95% CI 14 to 50; 9 studies, 4702 participants). </p> </li> <li> <p>Decreased <b>fungal sepsis</b> (typical RR 0.23, 95% CI, 0.10 to 0.54; RD ‐0.01, 95% CI, ‐0.02 to ‐0.01; NNTB 100, 95% CI 50 to 100; 6 studies, 3266 participants; moderate‐certainty evidence). </p> </li> <li> <p>Decreased <b>length of hospital stay</b> (MD ‐2.38, 95% CI, ‐4.67 to ‐0.09; 3 studies, 1079 participants, low‐certainty evidence). </p> </li> <li> <p>Decreased <b>urinary tract infection</b> (typical RR 0.33, 95% CI, 0.13 to 0.86; RD ‐0.03, 95% CI, ‐0.05 to ‐0.01; NNTB 33, 95% CI 20 to 100; 3 studies, 854 participants, low‐certainty evidence). </p> </li> </ul> </p> <p>There were no differences in:</p> <p> <ul id="CD007137-list-0012"> <li> <p><b>NEC</b> stage II or III (typical RR 1.10, 95% CI, 0.86 to 1.41; typical RD ‐0.00, 95% CI, ‐0.02 to 0.01; 7 studies, 4874 participants; low‐certainty evidence). </p> </li> <li> <p><b>'All‐cause mortality'</b> (typical RR 0.90, 95% CI 0.69 to 1.17; typical RD ‐0.00, 95% CI, ‐0.01 to 0.01; 11 studies, 5510 participants; very low‐certainty evidence). </p> </li> <li> <p><b>Chronic lung disease</b> (typical RR 1.00, 95% CI 0.89 to 1.12; typical RD 0.00, 95% CI ‐0.03 to 0.03; 5 studies, 2984 participants; moderate‐certainty evidence). </p> </li> <li> <p><b>Duration of mechanical ventilation</b> (MD ‐0.45, 95% CI, ‐1.30 to 0.39; 3 studies, 925 participants; low‐certainty evidence). </p> </li> <li> <p><b>Threshold retinopathy of prematurity</b> (typical RR 0.88, 95% CI, 0.69 to 1.13; RD ‐0.01, 95% CI, ‐0.02 to 0.01; 5 studies, 4515 participants; low‐certainty evidence). </p> </li> <li> <p><b>Neurodevelopmental outcomes</b> at 24 months of age by Mullen and Bayley III developmental tests: </p> </li> </ul> </p> <p> <ol id="CD007137-list-0013"> <li> <p><b>Mullen:</b> The estimated mean differences for subcomponents of the Mullen testing were: composite MD 0.70 [‐2.36, 3.76], gross motor ‐1.00 [‐2.71, 0.71], visual reception 0.60 [‐1.53, 2.73], fine motor ‐0.60 [‐2.92, 1.72], receptive language 0.30 [‐2.42, 3.02] and expressive language 0.90 [‐0.83, 2.63], 1 study, 292 participants, low‐certainty evidence. </p> </li> <li> <p><b>Bayley III</b>: The estimated mean differences for subcomponents of the Bayley III testing were: cognitive MD ‐0.70 [‐2.70, 1.30], language 1.20 [‐1.24, 3.64], motor ‐0.90 [‐3.73, 1.93] and social emotional score ‐1.00 [‐5.98, 3.98], 1 study, 292 participants, low‐certainty evidence. </p> </li> </ol> </p> <p>In subgroup analyses, extremely low birth weight (ELBW) infants and those fed exclusively maternal milk showed a reduction in late‐onset sepsis after oral lactoferrin supplementation (1 study; low‐certainty evidence). Investigators reported no differences in chronic lung disease or duration of mechanical ventilation. </p> <p><b>II. Lactoferrin supplementation to enteral feeds with probiotics</b> </p> <p> <ul id="CD007137-list-0014"> <li> <p><b>Decreased</b> <b>late‐onset sepsis</b> (typical RR 0.25, 95% CI 0.14 to 0.46; RD ‐0.13, 95% CI ‐0.18 to ‐0.08; NNTB 8, 95% CI 6 to 13; 3 studies, 564 participants; low‐certainty evidence). All 3 included studies reported data on <b>confirmed sepsis</b> only. </p> </li> <li> <p><b>Decreased fungal sepsis</b> (typical RR 0.24, 95% CI 0.08 to 0.71; RD ‐0.05, 95% CI ‐0.09 to ‐0.02; NNTB 20, 95% CI 11 to 50; 2 studies, 494 participants; low‐certainty evidence). </p> </li> <li> <p><b>Decreased NEC stage II or III</b> (typical RR 0.04, 95% CI 0.00 to 0.62; RD ‐0.05, 95% CI ‐0.08 to ‐0.03; NNTB 20, 95% CI 12.5 to 33.3; 1 study, 496 participants; very low‐certainty evidence). </p> </li> <li> <p>No differences on '<b>all‐cause mortality'</b> (typical RR 0.58, 95% CI 0.30 to 1.13; RD ‐0.03, 95% CI ‐0.06 to 0.01; 2 studies, 671 participants; very low‐certainty evidence). </p> </li> <li> <p>No differences in <b>chronic lung disease, urinary tract infection, duration of mechanical ventilation</b> , or <b>length of hospital stay</b>. </p> </li> </ul> </p> <p>Investigators did not report any adverse effects related to lactoferrin supplementation nor to the probiotic. None of the included studies assessed long‐term neurological outcomes or periventricular leukomalacia (PVL). </p> </section> <section id="CD007137-sec-0091"> <h3 class="title" id="CD007137-sec-0091">Overall completeness and applicability of evidence</h3> <p>The 12 randomized controlled trials were performed in neonatal intensive care units in Italy, New Zealand, the United States, Peru, Turkey, Canada, India, the United Kingdom, Australia &amp; New Zealand, and China. Trials are currently ongoing in Egypt and the Netherlands. Studies have evaluated enteral lactoferrin in both the developing and the developed world. </p> <p>We assessed visual asymmetry of the funnel plot for the outcome of 'late‐onset sepsis' and 'all‐cause mortality' where more than 10 trials provided data for inclusion (<a href="#CD007137-fig-0001">Figure 1</a>; <a href="#CD007137-fig-0002">Figure 2</a>). The visual analysis showed asymmetry of the funnel plot, with more trials with a positive outcome and few trials with no effect or negative outcomes. The asymmetry can be explained by publication bias but also by many small studies (<a href="./references#CD007137-bbs2-0001" title="AkinIM , AtasayB , DoguF , OkuluE , ArsanS , KaratasHD , et al. Oral lactoferrin to prevent nosocomial sepsis and necrotizing enterocolitis of premature neonates and effect on T-regulatory cells. American Journal of Perinatology2014;31(12):1111-20. [DOI: 10.1055/s-0034-1371704] [PMID: 24839144] [PMID: 24839144]">Akin 2014</a>; <a href="./references#CD007137-bbs2-0002" title="BarringtonKJ , AssaadMA , JanvierA . The Lacuna Trial: a double-blind randomized controlled pilot trial of lactoferrin supplementation in the very preterm infant. Journal of Perinatology2016;36(8):666-9. [DOI: 10.1038/jp.2016.24] [PMID: 26938920] [PMID: 26938920]">Barrington 2016</a>; <a href="./references#CD007137-bbs2-0003" title="DaiJZ , XieC . The effect of lactoferrin supplementation combining Lactobacillus rhamnosus for prevention of late onset sepsis in premature neonates. China Practical Medicine2015;10:98-100. ">Dai 2015</a>; <a href="./references#CD007137-bbs2-0005" title="KaurG , GathwalaG . Efficacy of bovine lactoferrin supplementation in preventing late-onset sepsis in low birth weight neonates: a randomized placebo-controlled clinical trial. Journal of Tropical Pediatrics2015;61(5):370-6. [DOI: 10.1093/tropej/fmv044] [PMID: 26224129]">Kaur 2015</a>; <a href="./references#CD007137-bbs2-0007" title="LiuYH , GuanHS , LiangGJ , LiYZ , ZuoA . The effect of lactoferrin on low birth weight neonates during hospitalization. Maternal and Child Health Care of China2016;31(21):4464-5. ">Liu 2016</a>; <a href="./references#CD007137-bbs2-0009" title="OchoaTJ , ZegarraJ , CamL , LlanosR , PezoA , CruzK , et al. Randomized controlled trial of lactoferrin for prevention of sepsis in Peruvian neonates less than 2500 g. Pediatric Infectious Disease Journal2015;34(6):571-6. [DOI: 10.1097/INF.0000000000000593] [PMID: 25973934]">Ochoa 2015</a>; <a href="./references#CD007137-bbs2-0011" title="ShermanMP , AdamkinDH , NiklasV , RadmacherP , ShermanJ , WertheimerF , et al. Randomized controlled trial of talactoferrin oral solution in preterm infants. Journal of Pediatrics2016;175:68-73. [DOI: 10.1016/j.jpeds.2016.04.084] [PMID: 27260839]">Sherman 2016</a>; and <a href="./references#CD007137-bbs2-0012" title="TangJP , SunHQ , ZhengYH , LuGH . Randomized control trial of lactoferrin for the prevention of late onset sepsis in premature neonates. Maternal and Child Health Care of China2017;32(6):1223-5. ">Tang 2017</a>), some with poor methodological quality inflating the effects of enteral lactoferrin supplementation. We have downgraded the evidence based on publication bias, small studies with poor methodological certainty for the outcomes of late‐onset sepsis and 'all‐cause mortality'. </p> <p>A major concern of investigators in the initial trials was safety of enteral lactoferrin in preterm neonates, especially ELBW infants, who are at high risk of developing sepsis and NEC. In this review involving more than 5200 preterm neonates, researchers observed no adverse effects due to enteral lactoferrin. One trial evaluated human recombinant lactoferrin; all other trials used bovine lactoferrin. Bovine lactoferrin has a 69% DNA sequence homology to human lactoferrin (<a href="./references#CD007137-bbs2-0049" title="PierceA , ColavizzaD , BenaissaM , MaesP , TartarA , MontreuilJ , et al. Molecular cloning and sequence analysis of bovine lactotransferrin. European Journal of Biochemistry1991;196(1):177-84. [PMID: 2001696]">Pierce 1991</a>). Differences in glycosylation patterns of human recombinant and bovine lactoferrins may be responsible for differences in susceptibility to proteolysis and pathogen adhesion (<a href="./references#CD007137-bbs2-0022" title="BarbozaM , PinzonJ , WickramasingheS , FroehlichJ , MoellerI , SmilowitzJ , et al. Glycosylation of human milk lactoferrin exhibits dynamic changes during early lactation enhancing its role in pathogenic bacteria-host interactions. Molecular Cell Proteomics2012;11(6):M111.015248. [DOI: 10.1074/mcp.M111.015248] [PMID: 22261723]">Barboza 2012</a>; <a href="./references#CD007137-bbs2-0024" title="BellamyW , TakaseM , WakabayashiH , KawaseK , TomitaM . Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. Journal of Applied Bacteriology1992;73(6):472-9. [PMID: 1490908]">Bellamy 1992</a>). Whether human lactoferrin is as effective in vivo as bovine lactoferrin, or whether higher doses of human lactoferrin can be tolerated, needs to be confirmed in future trials. </p> <p>The optimal timing of prophylaxis is unclear but supplementation as early as possible after birth appeals to reason. Three trials recruited subjects within the first three days of life <a href="./references#CD007137-bbs2-0004" title="ISRCTN88261002. Enteral lactoferrin supplementation for very preterm infants: a randomised controlled trial. isrctn.com/ISRCTN88261002 (first received 5 June 2013). [DOI: 10.1186/ISRCTN88261002]">ELFIN 2018</a>; <a href="./references#CD007137-bbs2-0008" title="ManzoniP , MeyerM , StolfiI , RinaldiM , CattaniS , PugniL , et al. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial. Early Human Development2014;90 Suppl 1:S60-5. [DOI: 10.1016/S0378-3782(14)70020-9] [PMID: 24709463]ManzoniP , RinaldiM , CattaniS , PugniL , RomeoMG , MessnerH , et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA2009;302(13):1421-8. [DOI: 10.1001/jama.2009.1403] [PMID: DOI: 10.1001/jama.2009.1403; PubMed: 19809023]]ManzoniP , StolfiI , MessnerH , CattaniS , LaforgiaN , RomeoMG , et al. Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial. Pediatrics2012;129(1):116-23. [PMID: 10.1542/peds.2011-0279; PubMed: 22184648]]">Manzoni 2014</a> and <a href="./references#CD007137-bbs2-0010" title="OchoaT , ZegarraJ , BellomoS , CarcamoC , CamL , CastanedaA , et al, Neolacto Research Group. Randomized controlled trial of bovine lactoferrin for prevention of sepsis and neurodevelopmental impairment in infants weighing less than 2000 grams. Journal of Pediatrics (in press) 2020. ">Ochoa 2020</a> and one recent trial in the first seven days of life (<a href="./references#CD007137-bbs2-0006" title="Tarnow-MordiWO , Abdel-LatifME , MartinA , PammiM , RobledoK , ManzoniP , et al, LIFT collaborators. The Lactoferrin Infant Feeding Trial (LIFT): a pragmatic, randomised, multicentre study in very low birth weight infants. Lancet. Child and Adolescent Health.2020;4(6):444-54 (with online Supplementary Appendix pp S1-44). [DOI: 10.1016/S2352-4642(20)30093-6]">LIFT 2020</a>). The duration of prophylaxis with enteral lactoferrin that provides optimal benefit without adverse effects for preterm neonates remains unclear but two recent large trials (<a href="./references#CD007137-bbs2-0004" title="ISRCTN88261002. Enteral lactoferrin supplementation for very preterm infants: a randomised controlled trial. isrctn.com/ISRCTN88261002 (first received 5 June 2013). [DOI: 10.1186/ISRCTN88261002]">ELFIN 2018</a>; <a href="./references#CD007137-bbs2-0006" title="Tarnow-MordiWO , Abdel-LatifME , MartinA , PammiM , RobledoK , ManzoniP , et al, LIFT collaborators. The Lactoferrin Infant Feeding Trial (LIFT): a pragmatic, randomised, multicentre study in very low birth weight infants. Lancet. Child and Adolescent Health.2020;4(6):444-54 (with online Supplementary Appendix pp S1-44). [DOI: 10.1016/S2352-4642(20)30093-6]">LIFT 2020</a>) continued lactoferrin till 34 weeks corrected gestational age and the latest study (<a href="./references#CD007137-bbs2-0010" title="OchoaT , ZegarraJ , BellomoS , CarcamoC , CamL , CastanedaA , et al, Neolacto Research Group. Randomized controlled trial of bovine lactoferrin for prevention of sepsis and neurodevelopmental impairment in infants weighing less than 2000 grams. Journal of Pediatrics (in press) 2020. ">Ochoa 2020</a>) for eight weeks after birth. It is not clear whether prophylaxis of increased duration is more effective in preventing late‐onset sepsis or NEC. Dosing based on birth weight (150‐300 mg/kg/day) was considered optimal and was used in the most recent trials (<a href="./references#CD007137-bbs2-0004" title="ISRCTN88261002. Enteral lactoferrin supplementation for very preterm infants: a randomised controlled trial. isrctn.com/ISRCTN88261002 (first received 5 June 2013). [DOI: 10.1186/ISRCTN88261002]">ELFIN 2018</a>; <a href="./references#CD007137-bbs2-0006" title="Tarnow-MordiWO , Abdel-LatifME , MartinA , PammiM , RobledoK , ManzoniP , et al, LIFT collaborators. The Lactoferrin Infant Feeding Trial (LIFT): a pragmatic, randomised, multicentre study in very low birth weight infants. Lancet. Child and Adolescent Health.2020;4(6):444-54 (with online Supplementary Appendix pp S1-44). [DOI: 10.1016/S2352-4642(20)30093-6]">LIFT 2020</a>; <a href="./references#CD007137-bbs2-0010" title="OchoaT , ZegarraJ , BellomoS , CarcamoC , CamL , CastanedaA , et al, Neolacto Research Group. Randomized controlled trial of bovine lactoferrin for prevention of sepsis and neurodevelopmental impairment in infants weighing less than 2000 grams. Journal of Pediatrics (in press) 2020. ">Ochoa 2020</a>). </p> </section> <section id="CD007137-sec-0092"> <h3 class="title" id="CD007137-sec-0092">Quality of the evidence</h3> <p>We assessed the certainty of evidence using the GRADE (Grades of Recommendation, Assessment, Development, and Evaluation) method (<a href="./references#CD007137-bbs2-0032" title="GuyattGH , OxmanAD , VistGE , KunzR , Falck-YtterY , Alonso-CoelloP , et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336(7650):924-6. [DOI: 10.1136/bmj.39489.470347.AD] [PMID: 18436948]">Guyatt 2008</a>); we downgraded the certainty of evidence to low or very low on the basis of potential risk of bias, availability of data from only one or two studies (imprecision), the presence of moderate to severe heterogeneity (inconsistency) and asymmetry of the funnel plot. Eight out of twelve included studies reported explicit randomization and allocation concealment without risk of bias. In the <a href="./references#CD007137-bbs2-0001" title="AkinIM , AtasayB , DoguF , OkuluE , ArsanS , KaratasHD , et al. Oral lactoferrin to prevent nosocomial sepsis and necrotizing enterocolitis of premature neonates and effect on T-regulatory cells. American Journal of Perinatology2014;31(12):1111-20. [DOI: 10.1055/s-0034-1371704] [PMID: 24839144] [PMID: 24839144]">Akin 2014</a>; <a href="./references#CD007137-bbs2-0003" title="DaiJZ , XieC . The effect of lactoferrin supplementation combining Lactobacillus rhamnosus for prevention of late onset sepsis in premature neonates. China Practical Medicine2015;10:98-100. ">Dai 2015</a>; <a href="./references#CD007137-bbs2-0007" title="LiuYH , GuanHS , LiangGJ , LiYZ , ZuoA . The effect of lactoferrin on low birth weight neonates during hospitalization. Maternal and Child Health Care of China2016;31(21):4464-5. ">Liu 2016</a>; and <a href="./references#CD007137-bbs2-0012" title="TangJP , SunHQ , ZhengYH , LuGH . Randomized control trial of lactoferrin for the prevention of late onset sepsis in premature neonates. Maternal and Child Health Care of China2017;32(6):1223-5. ">Tang 2017</a> studies, investigators could not assess generation of randomization sequences and allocation concealment, and the risk of selection bias was unclear. We noted that all included studies except <a href="./references#CD007137-bbs2-0003" title="DaiJZ , XieC . The effect of lactoferrin supplementation combining Lactobacillus rhamnosus for prevention of late onset sepsis in premature neonates. China Practical Medicine2015;10:98-100. ">Dai 2015</a>; <a href="./references#CD007137-bbs2-0007" title="LiuYH , GuanHS , LiangGJ , LiYZ , ZuoA . The effect of lactoferrin on low birth weight neonates during hospitalization. Maternal and Child Health Care of China2016;31(21):4464-5. ">Liu 2016</a>; and <a href="./references#CD007137-bbs2-0012" title="TangJP , SunHQ , ZhengYH , LuGH . Randomized control trial of lactoferrin for the prevention of late onset sepsis in premature neonates. Maternal and Child Health Care of China2017;32(6):1223-5. ">Tang 2017</a>, were at low or unclear risk for performance bias. In <a href="./references#CD007137-bbs2-0008" title="ManzoniP , MeyerM , StolfiI , RinaldiM , CattaniS , PugniL , et al. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial. Early Human Development2014;90 Suppl 1:S60-5. [DOI: 10.1016/S0378-3782(14)70020-9] [PMID: 24709463]ManzoniP , RinaldiM , CattaniS , PugniL , RomeoMG , MessnerH , et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA2009;302(13):1421-8. [DOI: 10.1001/jama.2009.1403] [PMID: DOI: 10.1001/jama.2009.1403; PubMed: 19809023]]ManzoniP , StolfiI , MessnerH , CattaniS , LaforgiaN , RomeoMG , et al. Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial. Pediatrics2012;129(1):116-23. [PMID: 10.1542/peds.2011-0279; PubMed: 22184648]]">Manzoni 2014</a>, researchers diluted interventions in feeds, and clinical and research staff were blinded to the intervention. Other included studies did not show risk of performance bias. None of the included studies explicitly reported blinding of outcome assessors (to minimize detection bias) except <a href="./references#CD007137-bbs2-0001" title="AkinIM , AtasayB , DoguF , OkuluE , ArsanS , KaratasHD , et al. Oral lactoferrin to prevent nosocomial sepsis and necrotizing enterocolitis of premature neonates and effect on T-regulatory cells. American Journal of Perinatology2014;31(12):1111-20. [DOI: 10.1055/s-0034-1371704] [PMID: 24839144] [PMID: 24839144]">Akin 2014</a>; <a href="./references#CD007137-bbs2-0004" title="ISRCTN88261002. Enteral lactoferrin supplementation for very preterm infants: a randomised controlled trial. isrctn.com/ISRCTN88261002 (first received 5 June 2013). [DOI: 10.1186/ISRCTN88261002]">ELFIN 2018</a>, <a href="./references#CD007137-bbs2-0006" title="Tarnow-MordiWO , Abdel-LatifME , MartinA , PammiM , RobledoK , ManzoniP , et al, LIFT collaborators. The Lactoferrin Infant Feeding Trial (LIFT): a pragmatic, randomised, multicentre study in very low birth weight infants. Lancet. Child and Adolescent Health.2020;4(6):444-54 (with online Supplementary Appendix pp S1-44). [DOI: 10.1016/S2352-4642(20)30093-6]">LIFT 2020</a>; and <a href="./references#CD007137-bbs2-0010" title="OchoaT , ZegarraJ , BellomoS , CarcamoC , CamL , CastanedaA , et al, Neolacto Research Group. Randomized controlled trial of bovine lactoferrin for prevention of sepsis and neurodevelopmental impairment in infants weighing less than 2000 grams. Journal of Pediatrics (in press) 2020. ">Ochoa 2020</a>. Investigators in included studies, except <a href="./references#CD007137-bbs2-0010" title="OchoaT , ZegarraJ , BellomoS , CarcamoC , CamL , CastanedaA , et al, Neolacto Research Group. Randomized controlled trial of bovine lactoferrin for prevention of sepsis and neurodevelopmental impairment in infants weighing less than 2000 grams. Journal of Pediatrics (in press) 2020. ">Ochoa 2020</a>, noted no attrition bias, performed all outcome assessments before hospital discharge, and adequately accounted for incomplete data. </p> </section> <section id="CD007137-sec-0093"> <h3 class="title" id="CD007137-sec-0093">Potential biases in the review process</h3> <p>We strove to decrease bias in the review process. Both review authors performed the literature search using an inclusive search strategy and combined search results. Our search strategy revealed fourteen reports on prespecified neonatal outcomes from 12 randomized clinical trials. Our post hoc analysis of evaluation of fungal sepsis, bacterial sepsis, threshold retinopathy of prematurity, or urinary tract infection did not change the conclusions of the review. We contacted investigators of published randomized controlled trials and searched conference proceedings for data and missing information with limited success. </p> </section> <section id="CD007137-sec-0094"> <h3 class="title" id="CD007137-sec-0094">Agreements and disagreements with other studies or reviews</h3> <p>We identified one review that synthesized data from trials of lactoferrin supplementation of enteral feeds in preterm neonates by meta‐analysis using a random‐effects model (<a href="./references#CD007137-bbs2-0034" title="HeY , CaoL , YuJ . Prophylactic lactoferrin for preventing late-onset sepsis and necrotizing enterocolitis in preterm infants. Medicine2018;97(35):e11976. [DOI: 10.1097/MD.0000000000011976] [PMID: 30170397]">He 2018</a>). This review included nine RCTs with 1834 participants and reported that lactoferrin enteral supplementation decreased late‐onset sepsis, NEC stage II or III, hospital‐acquired infection, infection‐related mortality, decreased time to full enteral feeds but no decrease in 'all cause mortality.' Our review found decreased late‐onset sepsis and fungal sepsis but decrease in NEC stage II or III only when lactoferrin was combined with probiotics. Our review also did not find any effect on 'all‐cause mortality.' <a href="./references#CD007137-bbs2-0048" title="OchoaTJ , SizonenkoSV . Lactoferrin and prematurity: a promising milk protein?Biochemistry and Cell Biology2017;95(1):22-30. [DOI: 10.1139/bcb-2016-0066] [PMID: 28085488]">Ochoa 2017</a> and <a href="./references#CD007137-bbs2-0062" title="TurinCG , Zea-VeraA , PezoA , CruzK , ZegarraJ , BellomoS , et al. Lactoferrin for prevention of neonatal sepsis. Biometals2014;27(5):1007-16. [DOI: 10.1007/s10534-014-9754-3] [PMID: 24935001]">Turin 2014</a> reviewed the details of published and ongoing clinical trials on oral lactoferrin prophylaxis in preterm neonates. <a href="./references#CD007137-bbs2-0044" title="LingappanK , ArunachalamA , PammiM . Lactoferrin and the newborn: current perspectives. Expert Reviews of Anti-Infective Therapy2013;11(7):695-707. [DOI: 10.1586/14787210.2013.811927] [PMID: 23879609]">Lingappan 2013</a> reviewed and expanded on the biology, anti‐microbial effects, and immunomodulatory effects of lactoferrin and commented on efficacy and safety related to its use in the newborn. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD007137-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/urn:x-wiley:14651858:media:CD007137:CD007137-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Lactoferrin supplementation with enteral feeds versus placebo, outcome: 1.1 Any late‐onset sepsis." data-id="CD007137-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-FIG-01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_t/tCD007137-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Lactoferrin supplementation with enteral feeds versus placebo, outcome: 1.1 Any late‐onset sepsis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/full#CD007137-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-FIG-01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007137-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/urn:x-wiley:14651858:media:CD007137:CD007137-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Lactoferrin supplementation with enteral feeds versus placebo, outcome: 1.3 All‐cause mortality." data-id="CD007137-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_t/tCD007137-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Lactoferrin supplementation with enteral feeds versus placebo, outcome: 1.3 All‐cause mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/full#CD007137-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007137-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/urn:x-wiley:14651858:media:CD007137:CD007137-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram for the updated search in January 20, 2020" data-id="CD007137-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-FIG-03.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_t/tCD007137-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Study flow diagram for the updated search in January 20, 2020</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/full#CD007137-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-FIG-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007137-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/urn:x-wiley:14651858:media:CD007137:CD007137-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD007137-fig-0004" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-FIG-04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_t/tCD007137-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/full#CD007137-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-FIG-04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007137-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/urn:x-wiley:14651858:media:CD007137:CD007137-FIG-05" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD007137-fig-0005" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-FIG-05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_t/tCD007137-FIG-05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/full#CD007137-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-FIG-05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007137-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/urn:x-wiley:14651858:media:CD007137:CD007137-FIG-06" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Lactoferrin supplementation with enteral feeds versus placebo, outcome: 1.1 Any late‐onset sepsis." data-id="CD007137-fig-0006" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-FIG-06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_t/tCD007137-FIG-06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Lactoferrin supplementation with enteral feeds versus placebo, outcome: 1.1 Any late‐onset sepsis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/full#CD007137-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-FIG-06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007137-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/urn:x-wiley:14651858:media:CD007137:CD007137-FIG-07" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Lactoferrin supplementation with enteral feeds versus placebo, outcome: 1.2 NEC ≥ stage II." data-id="CD007137-fig-0007" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-FIG-07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_t/tCD007137-FIG-07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Lactoferrin supplementation with enteral feeds versus placebo, outcome: 1.2 NEC ≥ stage II. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/full#CD007137-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-FIG-07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007137-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/urn:x-wiley:14651858:media:CD007137:CD007137-FIG-08" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Lactoferrin supplementation with enteral feeds versus placebo, outcome: 1.3 All‐cause mortality." data-id="CD007137-fig-0008" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-FIG-08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_t/tCD007137-FIG-08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 8</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Lactoferrin supplementation with enteral feeds versus placebo, outcome: 1.3 All‐cause mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/full#CD007137-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-FIG-08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007137-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/urn:x-wiley:14651858:media:CD007137:CD007137-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Lactoferrin supplementation with enteral feeds versus placebo, Outcome 1: Any late‐onset sepsis" data-id="CD007137-fig-0009" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_t/tCD007137-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Lactoferrin supplementation with enteral feeds versus placebo, Outcome 1: Any late‐onset sepsis </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/references#CD007137-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007137-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/urn:x-wiley:14651858:media:CD007137:CD007137-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Lactoferrin supplementation with enteral feeds versus placebo, Outcome 2: NEC ≥ stage II" data-id="CD007137-fig-0010" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_t/tCD007137-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Lactoferrin supplementation with enteral feeds versus placebo, Outcome 2: NEC ≥ stage II </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/references#CD007137-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007137-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/urn:x-wiley:14651858:media:CD007137:CD007137-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Lactoferrin supplementation with enteral feeds versus placebo, Outcome 3: All‐cause mortality" data-id="CD007137-fig-0011" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_t/tCD007137-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Lactoferrin supplementation with enteral feeds versus placebo, Outcome 3: All‐cause mortality </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/references#CD007137-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007137-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/urn:x-wiley:14651858:media:CD007137:CD007137-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Lactoferrin supplementation with enteral feeds versus placebo, Outcome 4: Bacterial sepsis" data-id="CD007137-fig-0012" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_t/tCD007137-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Lactoferrin supplementation with enteral feeds versus placebo, Outcome 4: Bacterial sepsis </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/references#CD007137-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007137-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/urn:x-wiley:14651858:media:CD007137:CD007137-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Lactoferrin supplementation with enteral feeds versus placebo, Outcome 5: Fungal infection" data-id="CD007137-fig-0013" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_t/tCD007137-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Lactoferrin supplementation with enteral feeds versus placebo, Outcome 5: Fungal infection </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/references#CD007137-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007137-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/urn:x-wiley:14651858:media:CD007137:CD007137-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Lactoferrin supplementation with enteral feeds versus placebo, Outcome 6: Chronic lung disease" data-id="CD007137-fig-0014" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_t/tCD007137-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Lactoferrin supplementation with enteral feeds versus placebo, Outcome 6: Chronic lung disease </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/references#CD007137-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007137-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/urn:x-wiley:14651858:media:CD007137:CD007137-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Lactoferrin supplementation with enteral feeds versus placebo, Outcome 7: Duration of mechanical ventilation" data-id="CD007137-fig-0015" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_t/tCD007137-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: Lactoferrin supplementation with enteral feeds versus placebo, Outcome 7: Duration of mechanical ventilation </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/references#CD007137-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007137-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/urn:x-wiley:14651858:media:CD007137:CD007137-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Lactoferrin supplementation with enteral feeds versus placebo, Outcome 8: Length of stay among survivors" data-id="CD007137-fig-0016" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_t/tCD007137-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: Lactoferrin supplementation with enteral feeds versus placebo, Outcome 8: Length of stay among survivors </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/references#CD007137-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007137-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/urn:x-wiley:14651858:media:CD007137:CD007137-CMP-001.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Lactoferrin supplementation with enteral feeds versus placebo, Outcome 9: Threshold retinopathy of prematurity" data-id="CD007137-fig-0017" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-001.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_t/tCD007137-CMP-001.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1: Lactoferrin supplementation with enteral feeds versus placebo, Outcome 9: Threshold retinopathy of prematurity </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/references#CD007137-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-001.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007137-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/urn:x-wiley:14651858:media:CD007137:CD007137-CMP-001.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Lactoferrin supplementation with enteral feeds versus placebo, Outcome 10: Urinary tract Infection" data-id="CD007137-fig-0018" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-001.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_t/tCD007137-CMP-001.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1: Lactoferrin supplementation with enteral feeds versus placebo, Outcome 10: Urinary tract Infection </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/references#CD007137-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-001.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007137-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/urn:x-wiley:14651858:media:CD007137:CD007137-CMP-001.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Lactoferrin supplementation with enteral feeds versus placebo, Outcome 11: Late onset sepsis ‐ good methodology studies" data-id="CD007137-fig-0019" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-001.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_t/tCD007137-CMP-001.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1: Lactoferrin supplementation with enteral feeds versus placebo, Outcome 11: Late onset sepsis ‐ good methodology studies </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/references#CD007137-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-001.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007137-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/urn:x-wiley:14651858:media:CD007137:CD007137-CMP-001.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Lactoferrin supplementation with enteral feeds versus placebo, Outcome 12: Neurodevelopemental outcome by Mullen at 24 months" data-id="CD007137-fig-0020" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-001.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_t/tCD007137-CMP-001.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1: Lactoferrin supplementation with enteral feeds versus placebo, Outcome 12: Neurodevelopemental outcome by Mullen at 24 months </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/references#CD007137-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-001.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007137-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/urn:x-wiley:14651858:media:CD007137:CD007137-CMP-001.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Lactoferrin supplementation with enteral feeds versus placebo, Outcome 13: Neurodevelopmental outcome by Bayley III at 24 months" data-id="CD007137-fig-0021" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-001.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_t/tCD007137-CMP-001.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1: Lactoferrin supplementation with enteral feeds versus placebo, Outcome 13: Neurodevelopmental outcome by Bayley III at 24 months </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/references#CD007137-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-001.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007137-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/urn:x-wiley:14651858:media:CD007137:CD007137-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Lactoferrin supplementation with enteral feeds in combination with probiotics versus placebo, Outcome 1: Any late‐onset sepsis" data-id="CD007137-fig-0022" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_t/tCD007137-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Lactoferrin supplementation with enteral feeds in combination with probiotics versus placebo, Outcome 1: Any late‐onset sepsis </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/references#CD007137-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007137-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/urn:x-wiley:14651858:media:CD007137:CD007137-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Lactoferrin supplementation with enteral feeds in combination with probiotics versus placebo, Outcome 2: NEC ≥ stage II" data-id="CD007137-fig-0023" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_t/tCD007137-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Lactoferrin supplementation with enteral feeds in combination with probiotics versus placebo, Outcome 2: NEC ≥ stage II </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/references#CD007137-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007137-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/urn:x-wiley:14651858:media:CD007137:CD007137-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Lactoferrin supplementation with enteral feeds in combination with probiotics versus placebo, Outcome 3: All‐cause mortality" data-id="CD007137-fig-0024" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_t/tCD007137-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Lactoferrin supplementation with enteral feeds in combination with probiotics versus placebo, Outcome 3: All‐cause mortality </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/references#CD007137-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007137-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/urn:x-wiley:14651858:media:CD007137:CD007137-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Lactoferrin supplementation with enteral feeds in combination with probiotics versus placebo, Outcome 4: Bacterial sepsis" data-id="CD007137-fig-0025" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_t/tCD007137-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: Lactoferrin supplementation with enteral feeds in combination with probiotics versus placebo, Outcome 4: Bacterial sepsis </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/references#CD007137-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007137-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/urn:x-wiley:14651858:media:CD007137:CD007137-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Lactoferrin supplementation with enteral feeds in combination with probiotics versus placebo, Outcome 5: Fungal Infection" data-id="CD007137-fig-0026" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_t/tCD007137-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: Lactoferrin supplementation with enteral feeds in combination with probiotics versus placebo, Outcome 5: Fungal Infection </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/references#CD007137-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007137-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/urn:x-wiley:14651858:media:CD007137:CD007137-CMP-002.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Lactoferrin supplementation with enteral feeds in combination with probiotics versus placebo, Outcome 6: Chronic lung disease" data-id="CD007137-fig-0027" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-002.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_t/tCD007137-CMP-002.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2: Lactoferrin supplementation with enteral feeds in combination with probiotics versus placebo, Outcome 6: Chronic lung disease </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/references#CD007137-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-002.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007137-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/urn:x-wiley:14651858:media:CD007137:CD007137-CMP-002.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Lactoferrin supplementation with enteral feeds in combination with probiotics versus placebo, Outcome 7: Duration of mechanical ventilation" data-id="CD007137-fig-0028" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-002.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_t/tCD007137-CMP-002.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2: Lactoferrin supplementation with enteral feeds in combination with probiotics versus placebo, Outcome 7: Duration of mechanical ventilation </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/references#CD007137-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-002.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007137-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/urn:x-wiley:14651858:media:CD007137:CD007137-CMP-002.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Lactoferrin supplementation with enteral feeds in combination with probiotics versus placebo, Outcome 8: Length of stay among survivors" data-id="CD007137-fig-0029" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-002.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_t/tCD007137-CMP-002.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2: Lactoferrin supplementation with enteral feeds in combination with probiotics versus placebo, Outcome 8: Length of stay among survivors </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/references#CD007137-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-002.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007137-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/urn:x-wiley:14651858:media:CD007137:CD007137-CMP-002.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Lactoferrin supplementation with enteral feeds in combination with probiotics versus placebo, Outcome 9: Threshold retinopathy of prematurity" data-id="CD007137-fig-0030" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-002.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_t/tCD007137-CMP-002.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2: Lactoferrin supplementation with enteral feeds in combination with probiotics versus placebo, Outcome 9: Threshold retinopathy of prematurity </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/references#CD007137-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-002.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007137-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/urn:x-wiley:14651858:media:CD007137:CD007137-CMP-002.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Lactoferrin supplementation with enteral feeds in combination with probiotics versus placebo, Outcome 10: Urinary tract infection" data-id="CD007137-fig-0031" src="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-002.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_t/tCD007137-CMP-002.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.10</div> <div class="figure-caption"> <p>Comparison 2: Lactoferrin supplementation with enteral feeds in combination with probiotics versus placebo, Outcome 10: Urinary tract infection </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/references#CD007137-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/media/CDSR/CD007137/image_n/nCD007137-CMP-002.10.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD007137-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Lactoferrin supplementation compared to control for very low birth weight infants</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Lactoferrin supplementation compared to control for very low birth weight infants</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> prevention of sepsis and necrotizing enterocolitis in preterm infants<br/><b>Setting:</b> Neonatal intensive care unit<br/><b>Intervention:</b> lactoferrin supplementation with enteral feeds<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>What happens</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Without lactoferrin supplementation with enteral feeds</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>With lactoferrin supplementation with enteral feeds</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Difference</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>All‐cause Mortality<br/>№ of participants: 5510<br/>(11 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>RR 0.97<br/>(0.79 to 1.20) </p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY </p> <p>LOW<sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Risk of bias, imprecision and funnel plot asymmetry</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5.9%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.7%<br/>(4.6 to 7) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2% fewer<br/>(1.2 fewer to 1.2 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>necrotizing enterocolitis<br/>№ of participants: 4874<br/>(7 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>RR 0.90<br/>(0.69 to 1.17) </p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Risk of bias in the included trials, and imprecision</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4.7%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.2%<br/>(3.2 to 5.5) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.5% fewer<br/>(1.4 fewer to 0.8 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Late onset sepsis<br/>№ of participants: 5425<br/>(12 RCTs) </p> <p>[Data includes both suspected and confirmed sepsis]</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>RR 0.80<br/>(0.72 to 0.89) </p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Risk of bias in the included trials, and asymmetry of the funnel plot</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>21.1%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17.3%<br/>(15.6 to 19.2) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.8% fewer<br/>(5.5 fewer to 1.9 fewer) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Bacterial sepsis<br/>№ of participants: 3565<br/>(8 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>RR 0.86<br/>(0.74 to 1.00) </p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Risk of bias and. moderate heterogeneity</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>16.1%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.9%<br/>(11.9 to 16.1) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.3% fewer<br/>(4.2 fewer to 0 fewer) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Fungal infection<br/>№ of participants: 3266<br/>(6 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>RR 0.23<br/>(0.10 to 0.54) </p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Risk of bias and moderate heterogeneity</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1.7%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.4%<br/>(0.2 to 0.9) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.3% fewer<br/>(1.5 fewer to 0.8 fewer) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Chronic lung disease<br/>№ of participants: 2984<br/>(5 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>RR 1.00<br/>(0.89 to 1.12) </p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Low risk of bias, moderate heterogeneity and imprecision</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>27.2%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27.2%<br/>(24.2 to 30.5) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.0% fewer<br/>(3 fewer to 3.3 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Length of hospital stay<br/>№ of participants: 1079<br/>(3 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean length of hospital stay without lactoferrin supplementation with enteral feeds was 34.14 days </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 2.38 days lower<br/>(4.67 lower to 0.09 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW<sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk of bias and severe heterogeneity</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Risk of bias, <sup>2</sup>imprecision, <sup>3</sup>funnel plot asymmetry </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Lactoferrin supplementation compared to control for very low birth weight infants</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/full#CD007137-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD007137-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Lactoferrin supplementation with enteral feeds in combination with probiotics compared to placebo for prevention of sepsis and necrotizing enterocolitis in preterm infants</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Lactoferrin supplementation with enteral feeds in combination with probiotics compared to placebo for prevention of sepsis and</b> necrotiz<b>ing enterocolitis in preterm infants</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> prevention of sepsis and necrotizing enterocolitis in preterm infants<br/><b>Setting:</b> Neonatal Intensive care unit<br/><b>Intervention:</b> Lactoferrin supplementation with enteral feeds in combination with probiotics<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with placebo</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with Lactoferrin supplementation with enteral feeds in combination with probiotics</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Any late‐onset sepsis ‐ All infants</p> <p>[Data on only confirmed sepsis available]</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.25<br/>(0.14 to 0.46) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>564<br/>(3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW<sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Risk of bias and imprecision</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>177 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>44 per 1,000<br/>(25 to 82) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>NEC ≥ stage II</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.04</p> <p>(0.00, 0.62)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>496<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Risk of bias and two levels for imprecision</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>54 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1,000<br/>(0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>All‐cause mortality</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.58</p> <p>(0.30, 1.13)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>671<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Risk of bias and two levels for imprecision</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>69 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1,000<br/>(0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Bacterial sepsis</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.28<br/>(0.11 to 0.72) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>319<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Risk of bias and imprecision</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>119 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>33 per 1,000<br/>(13 to 86) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Fungal Infection</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.24<br/>(0.08 to 0.71) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>494<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Risk of bias and imprecision</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>70 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>17 per 1,000<br/>(6 to 50) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Chronic lung disease</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.67<br/>(0.25 to 1.79) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>319<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Risk of bias and two levels for imprecision</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>60 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>40 per 1,000<br/>(15 to 107) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Length of stay among survivors</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 2 higher<br/>(1.88 lower to 5.88 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>496<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk of bias and two levels for imprecision</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Unclear blinding of intervention and outcome assessment, <sup>2</sup> Data from only one or few studies (imprecision) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Lactoferrin supplementation with enteral feeds in combination with probiotics compared to placebo for prevention of sepsis and necrotizing enterocolitis in preterm infants</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/full#CD007137-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007137-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Lactoferrin supplementation with enteral feeds versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Any late‐onset sepsis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 All infants with both suspected and culture proven sepsis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5425</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.72, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.2 Culture‐proven sepsis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5425</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.72, 0.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.3 Birth weight &lt; 1000 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.14, 0.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.4 Birth weight 1000‐1500 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>208</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.12, 1.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.5 Maternal milk‐fed infants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>685</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.81, 1.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.6 Formula‐fed infants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>159</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.38, 1.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 NEC ≥ stage II <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4874</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.69, 1.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5510</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.70, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Bacterial sepsis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3575</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.74, 1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Fungal infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3266</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.23 [0.10, 0.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Chronic lung disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2984</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.89, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Duration of mechanical ventilation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>925</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.45 [‐1.30, 0.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 Length of stay among survivors <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1079</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.38 [‐4.67, ‐0.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.9 Threshold retinopathy of prematurity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4515</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.69, 1.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.10 Urinary tract Infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>854</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.13, 0.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.11 Late onset sepsis ‐ good methodology studies <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5023</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.74, 0.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.12 Neurodevelopemental outcome by Mullen at 24 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.1 Composite</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>292</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [‐2.36, 3.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.2 Gross motor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>292</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.00 [‐2.71, 0.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.3 Visual reception</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>292</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [‐1.53, 2.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.4 Fine motor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>292</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.60 [‐2.92, 1.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.5 Receptive language</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>292</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [‐2.42, 3.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.6 Expressive language</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>292</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [‐0.83, 2.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.13 Neurodevelopmental outcome by Bayley III at 24 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.13.1 Cognitive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>224</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.70 [‐2.70, 1.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.13.2 Language</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>224</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [‐1.24, 3.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.13.3 Motor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>224</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.90 [‐3.73, 1.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.13.4 Social emotional score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>224</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.00 [‐5.98, 3.98]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Lactoferrin supplementation with enteral feeds versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/references#CD007137-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007137-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Lactoferrin supplementation with enteral feeds in combination with probiotics versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Any late‐onset sepsis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.1 All infants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>564</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.14, 0.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.2 Birth weight &lt; 1000 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [0.13, 0.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.3 Birth weight 1000‐1500 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [0.02, 1.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.4 Maternal milk‐fed infants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.07, 1.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.5 Formula milk‐fed infants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.01, 1.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 NEC ≥ stage II <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>496</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [0.00, 0.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>671</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.30, 1.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Bacterial sepsis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>319</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [0.11, 0.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 Fungal Infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>494</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [0.08, 0.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.6 Chronic lung disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>319</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.25, 1.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.7 Duration of mechanical ventilation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>319</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.10 [‐3.04, 0.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.8 Length of stay among survivors <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>496</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.00 [‐1.88, 5.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.9 Threshold retinopathy of prematurity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>319</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.39, 1.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.10 Urinary tract infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>319</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.25, 1.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Lactoferrin supplementation with enteral feeds in combination with probiotics versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007137.pub6/references#CD007137-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD007137.pub6&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD007137-note-0007">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD007137-note-0014">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD007137-note-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD007137-note-0013">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD007137-note-0010">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD007137-note-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD007137-note-0012">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD007137-note-0008">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD007137-note-0006">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007137\x2epub6\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007137\x2epub6\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007137\x2epub6\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007137\x2epub6"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007137\x2epub6\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007137\x2epub6\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007137\x2epub6\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007137\x2epub6\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007137\x2epub6\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007137\x2epub6"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007137\x2epub6\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007137\x2epub6\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007137\x2epub6\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007137\x2epub6"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007137\x2epub6\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007137\x2epub6\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007137\x2epub6\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007137\x2epub6"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=18M35a5z&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007137.pub6&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007137.pub6';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD007137.pub6/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD007137.pub6/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007137.pub6%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727300478"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007137.pub6/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727300482"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007137.pub6/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ea8b5d9859377',t:'MTc0MDcyNzMwMC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 